Page last updated: 2024-08-23

paroxetine and Depressive Disorder

paroxetine has been researched along with Depressive Disorder in 650 studies

Research

Studies (650)

Timeframe	Studies, this research(%)	All Research%
pre-1990	31 (4.77)	18.7374
1990's	295 (45.38)	18.2507
2000's	248 (38.15)	29.6817
2010's	71 (10.92)	24.3611
2020's	5 (0.77)	2.80

Authors

Authors	Studies
Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA	1
Bressolle-Gomeni, FMM; Fava, M; Gomeni, R; Goyal, N; Rabinowitz, J	1
Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC	1
Bianchi, L; Del Duca, E; Esposito, M; Fargnoli, MC; Giunta, A; Manfreda, V; Troisi, A	1
Hui, A	1
Fijałkowski, Ł; Kowalska, M; Nowaczyk, A; Nowaczyk, J	1
Brekke, M; Molden, E; Skogvoll, E; Spigset, O; Westin, AA	1
Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C	1
Bermudez, I; Csanova, A; Franklin, M; Hlavacova, N; Jezova, D; Li, Y; Sanchez, C	1
Emilsson, JF; Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S	1
Blanco, C; Cohen, JN; Drabick, DAG; Heimberg, RG; Liebowitz, MR; Schneier, FR	1
Bermudez, I; Csanova, A; Franklin, M; Hlavacova, N; Jezova, D; Li, Y; Pehrson, A; Sanchez, C	1
Ishigooka, J; Nishimura, K; Sawamura, J	1
Beyer, JL; Johnson, KG	1
Liu, CC; Qin, XM; Sun, N; Tian, JS; Xia, XT	1
Borrelli, J; Downs, DL; North, CS; Starr, A	1
Chen, L; Cheng, S; Guo, S; Xu, H	1
De Ronchi, D; Gibiino, S; Mori, E; Serretti, A	1
Abler, B; Graf, H; Metzger, CD; Walter, M	1
Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V	1
Atigari, OV; Healy, D; Jabeen, Q; Kelly, AM	1
Kamishioiri, Y; Kobayashi, D; Mine, K; Murata, Y; Sakamoto, S; Sugimoto, H; Tanaka, K	1
Groot, PC	1
Blackwell, KA; Forray, A; Glover, J; Yonkers, KA	1
Bortolatto, CF; Brüning, CA; Gai, BM; Nogueira, CW; Stein, AL; Zborowski, VA; Zeni, G	1
Becker, T; Koesters, M; Ma, Y; Zhang, Y	1
Balsevich, G; Dedic, N; Deussing, JM; Eder, M; Gassen, NC; Hafner, K; Hartmann, J; Holsboer, F; Ising, M; Kirmeier, T; Kloiber, S; Kollmannsberger, L; Lucae, S; Rein, T; Schmidt, MV; Stepan, J; Uhr, M; Wagner, KV; Zellner, A; Zschocke, J	1
Conca, A; Giupponi, G; Maniscalco, I; Toffol, E	1
Akil, H; Clinton, SM; Cohen, JL; Fant, AD; Glover, ME; Jackson, NL; Pugh, PC	1
Bressolle, F; Fava, M; Gomeni, R; Goyal, N	1
Benetti, F; Blandina, P; Cassano, T; Corradetti, R; Galeotti, N; Munari, L; Passani, MB; Provensi, G	1
Amodeo, LR; Crawford, CA; Eaton, SE; Greenfield, VY; Harmony, ZR; Humphrey, DE; Johnson, JD; Pipkin, JA; Plant, CP; Varela, V; Wang, L	1
Aparasu, RR; Bali, V; Carnahan, RM; Chatterjee, S; Chen, H; Johnson, ML	1
Boudreau, DM; Bowles, EJ; Buist, DS; Chubak, J; Fujii, M; Yu, O	1
Ho, RC; Zhang, MW	1
Dyer, C	1
Freitas, RM; Moreno, LCGEAI; Rolim, HML; Santos-Magalhães, NS	1
Jiang, CL; Liu, WZ; Shang, ZL; Wang, W; Xiang, ZH	1
Dudka, J; Poleszak, E; Serefko, A; Stasiuk, W; Świąder, K; Szopa, A; Wlaź, P; Wyska, E	1
Ahmed, R; Eagleton, C	1
Dernovsek, MZ; Sajovic, M; Tavcar, R	1
Haskis, A; Seedat, S; Stein, DJ	1
Frank, C	1
Diksic, M; Skelin, I; Yamane, F	1
Gómez-Grande, ML; Martín-Rodríguez, C; Ortega-Carnicer, J; Portilla-Botelho, M	1
Terao, T	2
Jureidini, J; Mintzes, B	1
Aizenstein, HJ; Becker, JT; Butters, MA; Carter, CS; Gianaros, PJ; Mazurkewicz, LM; Reynolds, CF; Stenger, VA; Wu, M	1
Bienfait, K; Buyske, S; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M	1
Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Iyengar, S; Keller, M; Kennard, B; Leonard, H; Mayes, T; McCracken, J; Porta, G; Ritz, L; Ryan, N; Shamseddeen, W; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD	1
Friedman, A; Lax, E; Lubin, N; Merenlender, A; Rosenstein, M; Yadid, G	1
Bellantuono, C; Gentile, S	1
Andersohn, F; Garbe, E; Schade, R; Suissa, S	1
Danhof, M; Della Pasqua, O; Santen, G	2
Colombo, C; De Ronchi, D; Kato, M; Kinoshita, T; Okugawa, G; Rossini, D; Serretti, A; Zanardi, R	1
Krulewicz, S; Mannelli, P; Marks, DM; Masand, PS; Pae, CU; Patkar, AA; Peindl, K	1
Ahrold, TK; Meston, CM	1
Argyropoulos, SV; Bell, CJ; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, S	1
Dubois, O	1
Smith, E	1
Einarson, A	2
Parish, SJ	1
DeVeaugh-Geiss, AM; Gaynes, BN; Kroenke, K; Miller, WC; Sleath, B; West, SL	1
Tanne, JH	1
Auerbach, S; Brass, SD	1
Blokland, A; Dawson, N; Ferrington, L; Kelly, PA; Prickaerts, J; Steinbusch, HW; van Donkelaar, EL	1
Boulenger, JP; Hermes, A; Huusom, AK; Weiller, E	1
Haraguchi, K; Ieiri, I; Imuta, N; Kobayashi, D; Koyama, S; Mine, K; Murata, Y; Nishimura, R	1
Collins, A; Gragg, M; Sherrod, RA; Wynn, S	1
Andersohn, F; Willich, SN	1
Austin, PC; Duong-Hua, M; Gomes, T; Juurlink, DN; Kelly, CM; Paszat, LF; Pritchard, KI	1
Aubry, JM; Bertschy, G; Bondolfi, G; Gervasoni, N; Gex-Fabry, M; Legendre-Simon, P	1
Jenkinson, ML	1
Fujiyama, Y; Kato, M; Kinoshita, T; Nishida, K; Sakai, S; Sugimoto, T; Suwa, A; Tajika, A; Takekita, Y; Wakeno, M	1
Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS	1
Dormuth, C; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS	1
Bienfait, KL; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M; Tröster, A	1
Favrelière, S; Jaafari, N; Nourrisson, A; Pérault Pochat, MC	1
Bérard, A; Broy, P; Nakhai-Pour, HR	1
Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J	1
Aitchison, KJ; Keers, R	1
Hori, H; Ikenouchi-Sugita, A; Iwata, N; Kishi, T; Nakamura, J; Otani, K; Suzuki, A; Umene-Nakano, W; Yoshimura, R	1
Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R	1
Cassano, GB; Mula, M; Pini, S; Preve, M	1
Roehr, B	1
Kaneda, A; Kaneko, S; Nakagami, T; Sato, Y; Yasui-Furukori, N	1
Gilbert, AL; Grzeskowiak, LE; Morrison, JL	1
Chamielec, M; Gałecki, P; Talarowska, M; Zboralski, K	1
Lee, KU; Lee, YM	1
Dahmen, N; Engel, A; Gerbaulet, M; Hiemke, C	1
Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA	1
Kobayashi, T; Yamauchi, M	1
Hazama, GI; Iwata, M; Nakagome, K	1
Friedman, JH; Weintraub, D	1
Black, KJ; Brodsky, M; Christine, CW; Como, PG; Elmer, L; Factor, SA; Fernandez, HH; Horn, S; Hyson, HC; Jiang, W; Juncos, J; Kurlan, R; Lyness, JM; Manning, C; Marsh, L; McDermott, MP; McDonald, W; Panisset, M; Pearson, N; Pfeiffer, R; Press, D; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J	1
Binder, EB; Ganea, K; Harbich, D; Holsboer, F; Liebl, C; Lucae, S; Menke, A; Müller, MB; Rammes, G; Schmidt, MV; Sillaber, I; Sterlemann, V; Storch, C; Uhr, M	1
Cox, GR; Hetrick, SE; McKenzie, JE; Merry, SN; Simmons, MB	1
Byatt, N; Deligiannidis, KM; Freeman, MP	1
Cunha, MP; Machado, DG; Oliveira, Á; Pazini, FL; Rodrigues, AL	1
Berard, RM	1
Baumann, P; Bovier, P; Eap, CB; Giannakopoulos, P; Giroud, C; Hilleret, H; Rivier, L; Voirol, P; Zullino, D	1
Dubé, EM; Golden, RN; McSorley, P; Nemeroff, CB; Pitts, CD	1
Black, DW	1
Jacobson, JG; Judge, R; Parry, MG; Quail, D	1
Kruizinga, MJ; Ramaekers, JG; Riedel, WJ; Schmitt, JA; van Boxtel, MP; Vuurman, EF	1
Begley, A; Frye, RF; Kirshner, M; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Solai, LK; Sorisio, D; Sweet, RA	1
Gilmor, ML; Nemeroff, CB; Owens, MJ	1
Kline, NA; Matloff, JL; Stein, MB	1
Benkert, O; Muller, M; Szegedi, A	1
Begg, EJ; Kennedy, MA; Roberts, R; Stedman, CA; Wilkinson, TJ	1
Begley, AE; Joo, JH; Lenze, EJ; Mazumdar, S; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Weber, EM	1
Botey, E; Herrero, C; Lecha, M; Romaguera, C; Vilaplana, J	1
Entsuah, R; Rudolph, RL; Stahl, SM	1
Ferguson, JM; Schwartz, GE; Wesnes, KA	1
Amador, XF; Baldini Rossi, N; Cassano, GB; Cassano, P; Dell'Osso, L; Pini, S; Savino, M	1
Finfgeld, DL	1
Braconnier, A; Cohen, D; Le Coent, R	1
Jakovljević, M; Mihaljević-Peles, A; Mück-Seler, D; Pivac, N; Sagud, M	1
Krishnan, R; Ranga, K	1
Chiu, CC; Huang, SY; Shen, WW; Su, KP	1
Carreira, I; Lima, L; Piñango, L; Pineda, S; Urbina, M	1
Baxter, LR; Brody, AL; Ho, ML; Maidment, KM; Saxena, S; Zohrabi, N	1
Fortmann, SP; Hayward, C; Killen, JD; Schatzberg, A; Varady, A	1
Jureidini, JN; Tonkin, AL	1
Aragües, E; Etxebeste, M; Malo, P; Medrano, J; Pacheco Yáñez, L	1
Bourin, M	1
Bachtold, D	1
Lo Sasso, AT; Sheffield, RE; Way, K; Young, CH	1
Angus, M; Crawford, GM; Hamilton, L; Wade, A; Wilson, R	1
Jureidini, J; Tonkin, A	1
Anghelescu, I; Benkert, O; Klawe, C; Kohnen, R; Müller, MJ; Szegedi, A	1
Kawashima, T; Yamada, S	1
Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN	1
Dew, MA; Houck, P; Mulsant, BH; Reynolds, CF; Szanto, K	1
Waechter, F	1
Nakamura, J; Sakata, Y; Shinkai, K; Ueda, N; Yoshimura, R	1
Hale, AS	1
Damsa, C; Schulz, P; Sterck, R	1
Burgmer, M; Driesch, G; Heuft, G	1
Arita, S; Morishita, S	1
Reynolds, CF	2
Whitehead, PD	1
Dew, MA; Houck, P; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF; Shear, MK	1
Oransky, I	1
Nemeroff, CB	2
Nakamura, J; Okamoto, K; Shinkai, K; Ueda, N; Yoshimura, R	1
Merlob, P; Stahl, B; Sulkes, J	1
Bramley, T; Eaddy, M; Regan, T	1
Avci, A; Diler, RS; Kibar, M	1
Swedo, S; Vitiello, B	1
Bang, LM; Keating, GM	1
Martini, P; Mazzatenta, C; Peonia, G	1
Lynch, A; Madjlessi, A	1
Knapp, M; Patel, A; Romeo, R; Thomas, C	1
Berman, N; Bowden, CL; Brannan, S; Frazer, A; Houston, JP; Katz, MM; Swann, AC	1
Langlands, A; Newton, J	1
Marshall, E	1
Friedli, L	1
Beebe, KL; Burgin, C; Masters, BK; Nawar, O; Parker, DE; Tucker, P; Wyatt, DB	1
Gibson, L	1
Hartter, S	1
Brown, EB; Joliat, MJ; Miner, CM	1
Eckert, G; Greco, T; Kroenke, K	1
Kramer, TA	1
Burrows, GD; Hindmarch, I; Kennedy, SH; Lejoyeux, M; Montgomery, SA	1
Brooks, SJ; Kutcher, S	1
Deuschle, M; Gilles, M; Hamann, B; Heuser, I; Luppa, P	1
Carfagno, ML; Dillingham, KE; Perera, P; Pigotti, TA; Pitts, CD; Trivedi, MH	1
Bindeballe, N; Colla, M; Deuschle, M; Gilles, M; Hamann, B; Heuser, I; Krumm, B; Lederbogen, F	1
Roth, M; Schulze, U; Strobel, M; Warnke, A	1
Cabanac, F; Panconi, E; Pezous, N; Sechter, D; Tournoux, A; Vandel, P; Weiller, E	1
Klemperer, I; Levy, J; Lifshitz, T; Shneck, M; Tessler, Z	1
Dienel, A; Kieser, M; Kohnen, R; Szegedi, A	1
Feiger, AD; Kobak, KA; Lipsitz, JD	1
Fernandez López, I; Guzmán Ruiz, O; Ramírez Martín del Campo, M; Romero Gómez, M	1
Amsterdam, JD; Brown, LL; DeRubeis, RJ; Gallop, R; Gladis, MM; Hollon, SD; Lovett, ML; O'Reardon, JP; Salomon, RM; Shelton, RC; Young, PR	1
Amsterdam, JD; DeRubeis, RJ; Freeman, BB; Gallop, R; Haman, KL; Hollon, SD; Lovett, ML; O'Reardon, JP; Salomon, RM; Shelton, RC; Young, PR	1
Azuma, J; Fukuda, K; Fukuda, T; Ikenaga, Y; Kato, M; Kinoshita, T; Nobuhara, K; Okugawa, G; Wakeno, M	1
Holsinger, T; Williams, JW	1
Akpinar, Z; Buyrac, Z; Colakoglu, O; Kupelioglu, A; Tankurt, E; Ugur, F; Unsal, B	1
Lai, H; Tolat, R	1
Iga, J; Morita, K; Motoki, I; Ohmori, T; Ohta, K; Rokutan, K; Song, H; Tayoshi, S; Ueno, S; Yamauchi, K	1
Carpenter, D; Connor, K; Davidson, J; Krishnan, R; Krulewicz, S; Nemeroff, C; Owens, M; Watkins, L	1
Clarke, P; Haddad, PM; Pal, BR; Sridhiran, S; Wieck, A	1
Creed, F; Fernandes, L; Guthrie, E; Ratcliffe, J; Read, N; Rigby, C; Thompson, DG; Tomenson, B	1
Kozian, R	1
Eaddy, MT; Mauch, RP; Shah, MB; Sheehan, DV	1
Eaddy, MT; Keene, MS; Nelson, WW; Sarnes, MW	1
Bremner, JD; Foa, EB; Mayberg, HS; Nemeroff, CB; North, CS; Stein, MB	1
Christi, JA; Perera, P; Pitts, CD; Roy-Byrne, PP	1
Bobrov, AS; Kovaleva, AV; Pavlova, ON; Petrun'ko, OV	1
Lang, AE; Voon, V	1
Fabian, Z; Karányi, Z; Szádóczky, E	1
Belin, T; Chung, J; Green, BL; Krupnick, JL; Miranda, J; Revicki, D; Siddique, J	1
Carpenter, DJ; Fong, R; Horrigan, JP; Krulewicz, S; Lipschitz, A; Perera, P; Wagner, KD	1
Davidson, JR	1
Kubota, T; Miyata, A	1
Bies, RR; Feng, Y; Ferrell, RE; Kimak, MA; Pollock, BG; Reynolds, CF	1
Fujita, K; Ichihashi, K; Inoue, K; Okazaki, Y; Tanii, H	1
Einarson, A; Koren, G	1
Bourin, M; Chenu, F; Gardier, AM; Guiard, BP	1
de Jong-van den Berg, L; Egberts, T; Kaasenbrood, H; Schobben, F; Ververs, T; Visser, G	1
Krol, DG; Nolen, WA	1
Nakao, M; Nomura, K; Takeuchi, T; Teramoto, T; Yano, E	1
Bech, P; Kajdasz, DK; Porsdal, V	1
Bailly, D	1
Alvarez, E; Bullich, S; Catafau, AM; Corripio, I; Danus, M; Pascual, JC; Penengo, MM; Perez, V; Perich, J; Plaza, P; Puigdemont, D; Suarez, M	1
Haro, JM; Peñarrubia, MT; Pinto-Meza, A; Serrano-Blanco, A; Suárez, D	1
Einarson, A; Wood, W	1
Grochowik, AM	1
Rottmann, CN	1
Kishi, Y	1
Li, SJ; Liu, T	1
Escrivá-Moscardó, S; Llinares-Tello, F; Martínez-Mascaraque, P; Martínez-Pastor, F	1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J	1
de la Rosa M, A; De Las Cuevas, C; Sanz, EJ; Troyano, JM	1
Hori, H; Mitoma, M; Nakamura, J; Okamoto, T; Sugita, A; Ueda, N; Umene, W; Yoshimura, R	1
Heerdink, ER; van Dijk, L; Volkers, AC	1
Hetrick, S; McKenzie, J; Merry, S; Proctor, M; Sindahl, P	1
Haraguchi, K; Hosoi, M; Ieiri, I; Iwata, N; Kinukawa, N; Kobayashi, D; Mine, K; Murakami, Y; Ohtani, H; Ozaki, N; Sawada, Y; Suzuki, T; Tanaka, M	1
Drago, F; Leggio, GM; Micale, V	1
Ball, WA; Lines, CR; Liu, KS; Potter, WZ; Reines, SA; Snavely, DB	1
Bakker, MK; de Jong van den Berg, LT; de Walle, HE; Kölling, P; van den Berg, PB	1
Ikeda, A; Ueki, M; Ushiroyama, T	1
Spielmans, GI	1
Bleau, P; Chokka, PR; Filteau, MJ; Katzman, MA; Kjernisted, KD; McIntosh, D; Mok, H; Pham, B; Tricco, AC	1
Amsterdam, JD; DeRubeis, RJ; Fournier, JC; Gallop, R; Hollon, SD; Shelton, RC	1
Brenninkmeijer, VJ; Derijks, LJ; Egberts, TC; Hougardy, DM; van der Graaf, F	1
Deuschle, M; Hellweg, R; Heuser, I; Ziegenhorn, A	1
Carpenter, DJ; Krulewicz, S; Nemeroff, CB; Owens, MJ; Plott, SJ; Sheehan, DV; Simon, JS; Thase, ME	1
Butters', MA; Carreira, K; Dew, MA; Frank, E; Houck, PR; Miller, MD; Morse, JQ; Reynolds, CF	1
Børup, C; le Fèvre Honoré, P; Meidahl, B; Petersen, IM; Vangtorp, A	1
Detroux, D; Kerkhofs, M; Leyman, S; Linkowski, P; Mendlewicz, J; Staner, L	1
Curran, S	1
Dunbar, GC	1
Alling, C; Dalgaard, L; Lundmark, J; Manniche, PM; Wålinder, J	1
Barg, T; Grünewald, I; König, F; Leibfarth, M; Wetzel, S; Wolfersdorf, M	1
Owens, DW	1
Cesková, E; Kamenická, V; Novotný, V; Obrovská, V; Svestka, J	1
Albritton, J; Borison, RL	1
Rothschild, AJ	1
Bardgett, ME; Black, KJ; Csernansky, JG; Sheline, YI	1
Arora, RC; Crayton, JW; Fichtner, CG; O'Connor, FL; Yeoh, HC	1
Black, KJ; Sheline, YI	2
Baumann, P; Rochat, B	1
Barg, T; Grünewald, I; König, F; Leibfarth, M; Wolfersdorf, M	1
Camprubi, ME; Puri, BK	1
Gelenberg, AJ; Ottosson, JO	1
Debattista, C; Schatzberg, AF	1
Preskorn, SH	2
Christensen, RC	2
Finley, PR	1
Bushnell, WD; Kreider, MS; Oakes, R; Wheadon, DE	1
Adler, LA; Angrist, BM	1
Goodnick, PJ; Henry, J; Kumar, A	1
Bardgett, ME; Csernansky, JG; Jackson, JL; Newcomer, JW; Sheline, YI	1
Freemantle, N; House, A; Mason, J; Sheldon, T; Song, F	1
Cosyns, P; D'Hondt, P; Gommeren, W; Leysen, JE; Maes, M; Scharpé, S	1
Pyke, RE	1
Hirschfeld, RM	1
Cavanaugh, E; Heiser, JF; Linden, RD; Wilcox, CS; Wisselink, PG	1
Folkerts, H	1
Allen, SA; Malek-Ahmadi, P	1
Abou-Saleh, MT; Burns, RA; Edwards, DR; Harrison, DA; Horton, RW; Katona, CL; Lawrence, KM; Lock, T; Nairac, BL; Robertson, MM	1
O'Brien, JT	1
Bakish, D; Chudzik, J; Hrdina, PD; Lapierre, YD; Ravindran, A	1
Falkowski, J; Horton, RW; Jacobson, RR; Lawrence, KM	1
Rechlin, T	1
Zelwer, A	1
Cizadlo, BC; Wheaton, A	1
Bebbington, PE; Jönsson, B	1
Craighead, WE; Franks, J; Knight, DL; Krishnan, KR; Nemeroff, CB	1
Ludwig, M; Schöne, W	2
Fleischhacker, WW; Geretsegger, C; Hinterhuber, H; König, P; Platz, T; Schubert, H; Stuppaeck, CH; Whitworth, AB	1
Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF	1
Preskorn, S	1
Domino, EF; Holmes, RD; Lee, A; Markel, H	1
Eriksen, J; Jensen, NH; Lauritzen, L; Lunde, M; Mellerup, ET; Plenge, P	1
Dunner, DL	1
Asai, K; Mori, H; Nankai, M; Toru, M; Watanabe, A; Yamada, S; Yoshimoto, S	1
Bialik, RJ; Chudzik, J; Hrdina, PD; Lapierre, YD; Ravindran, AV	1
Claus, D; Rechlin, T; Weis, M	1
Arminen, SL; Ikonen, U; Koponen, H; Korpela, V; Kourula, K; Lehtonen, ML; Leinonen, E; Mahlanen, A; Pulkkinen, P; Ryyppö, J	1
Tignol, J	1
Stokes, PE	1
Claghorn, JL; Feighner, JP	1
Duboff, EA	1
Alvarez, E; Artigas, F; Perez, V	1
Huls, J; Ottervanger, JP; Stricker, BH; Weeda, JN	1
Böhmer, F; Geretsegger, C; Ludwig, M	1
Möller, HJ; Steinmeyer, EM	2
Scheen, AJ	1
Caley, CF; Weber, SS	1
McDougle, CJ; Price, LH; Sherman, TL	1
Dunbar, G; Montgomery, SA	1
Gerber, J; Jimerson, D; Salzman, C; Vasile, R; Watsky, E	1
Barr, LC; Goodman, WK; Price, LH	1
Chudzik, J; Strijewski, A; Tang, SW	1
Demeter, E; Hrdina, PD; Palkovits, M; Sótónyi, P; Vu, TB	1
Cohn, JB; Dunbar, GC; Fabre, LF; Feighner, JP; Fieve, RR; Mendels, J; Shrivastava, RK	2
Berzewski, H; Eckmann, F; Gonzalves, N; Kissling, W; Knorr, W; Magyar, I; Möller, HJ; Ressler, P; Rudolf, GA; Steinmeyer, EM	1
Kupfer, DJ	1
Bartholomé, F; De Wilde, J; Leyman, S; Mertens, C; Schotte, G; Spiers, R	1
Feldtrauer, JJ; Germer, M; Graf, T; Howald, H; Waldmeier, PC	1
Claghorn, JL; Dunbar, GC; Kiev, A; Rickels, K; Smith, WT	2
Buchholtz-Hansen, PE; Kragh-Sørensen, P; Wang, AG	1
Crosby, J; Flint, AJ; Genik, JL	1
Carleborg, L; Norström, A; Sandlund, M; Spigset, O	1
Bentkover, J; Lapierre, Y; Manners, S; Schainbaum, S	1
Bardgett, ME; Csernansky, JG; Jackson, JL; Nelson, EC; Sheline, YI	1
Arya, DK; McKenzie, J; Worrall, N	1
Cole, JO; Diamond, L; Pillay, SS; Stoll, AL; Workum, SB	1
Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT	1
Abed, RT; Ascher, A; Baldwin, DS; Buckingham, SA; Cox, J; Hawley, CJ; Maragakis, BP; Pover, GH	1
Newhouse, PA	1
Bertholon, F; el Allali, A; Krajewski, Y	1
Koller-Leiser, A; Schnyder, U	1
Behnke, K; Black, CH; Bork-Rasmussen, H; Christiansen, PE; Nilsson, J; Ohrström, JK	1
Botsaris, SD; Sypek, JM	1
Fava, GA; Grandi, S	1
Liebowitz, MR; Marshall, RD	1
Cua, W; Dominguez, RA; Kumar, AM	1
Lesaca, TG	1
Altieri, L; Finkel, MS; Laghrissi-Thode, F; Miller, MC; Mulsant, BH; Pollock, BG	1
Aragues, E; Etxebeste, M; Malo, P; Pacheco, L	1
McCook, EC; Ritchie, JC; Seidler, FJ; Slotkin, TA	1
Pinkofsky, HB; Reeves, RR	1
Begley, A; Cornes, C; Dew, MA; Frank, E; Hall, M; Houck, PR; Kupfer, DJ; Mazumdar, S; Miller, MD; Mulsant, B; Perel, JM; Reynolds, CF; Shear, MK	1
Arya, DK	1
Cowen, PJ; McTavish, SF; Williamson, DJ	1
Leo, RJ	1
Hurwitz, TA; Mithani, H	1
Bech, P; Black, C; Clemmesen, L; Lauritzen, L; Lunde, M; Odgaard, K; Ohrström, J	1
de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR	1
Hawley, CJ; McPhee, S; Pattinson, HA; Quick, SJ; Ratnam, S	1
Albers, LJ; Helmeste, D; Reist, C; Tang, SW; Vu, R	1
Franchini, L; Gasperini, M; Perez, J; Smeraldi, E; Zanardi, R	2
Boerner, RJ; Hegerl, U; Helmchen, C; Meyendorf, R	1
Häfele, M; Hauger, B; König, F; Löble, M; Wolfersdorf, M; Wössner, S	1
Landry, P; Roy, L	1
Díez-Manrique, JF; Herrán, A; Palacios-Araus, L; Vázquez-Barquero, JL	1
König, F; Löble, M; Wolfersdorf, M	1
Bauer, M; Baumgartner, A; Hellweg, R	1
Bakish, D; Cavazzoni, P; Chudzik, J; Hrdina, PD; Ravindran, A	1
Meister, W; Zaninelli, R	1
Hays, P	1
Alonso, M; Rapaport, MH; Val, E	1
Rifkin, A	1
Fischer, P; Goessler, R; Kasper, S; Vesely, C	1
Charness, WE; Ferrando, SJ; Goldman, JD	1
Bray, J; Hunter, BN; Judge, R; Morton, NH; Ravindran, AV	1
DeQuardo, JR; DuBose, C; Lewis, CF; Tandon, R	1
Brink, DD; Carroll, NV; Farrar, TW; Kirkwood, CK; Melton, ST	1
Benkert, O; Meister, W; Philipp, M; Staab, HJ; Szegedi, A; Wetzel, H	1
Kraus, RP	1
Feiger, A; Kiev, A	1
Berigan, TR; Cannard, AW; Cannard, KR	1
Crompton, MR; De Paermentier, F; Horton, RW; Katona, CL; Lawrence, KM; Lowther, S	1
Darby, AL; Lesser, IM; Miller, BL; Swartz, JR	1
Sagduyu, K	1
Alvarez, P; Arranz, B; Lirón, F; Menchón, JM; Navarro, MA; Rosel, P; Vallejo, J	1
Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP	1
Angersbach, D; Benkert, O; Dunbar, GC; Philipp, M; Schwarze, H; Szegedi, A; Wetzel, H	1
Harte, R; Holland, C; Isaac, MT; Tome, MB	1
Marcheschi, M; Masi, G; Pfanner, P	1
Adès, J; Lejoyeux, M	1
Cloninger, CR; Isaac, MT; Tome, MB; Watson, JP	1
Bordet, R; Dupuis, B; Thomas, P	2
Isaac, MT; Tome, MB	4
Bizouard, P; Bonin, B; Sechter, D; Vandel, P	1
Alderman, CP; Hundertmark, JD; Soetratma, TW	1
Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR	1
Angersbach, D; Benkert, O; Philipp, M; Szegedi, A; Wetzel, H	1
Boyer, W	1
Gutiérrez-Casares, JR; Rey-Sánchez, F	1
Assion, HJ; Ehrlich, M; Heinemann, F; Hermes, G	1
Gregor, KJ; James, SP; Way, K; Young, CH	1
Flint, A	1
Artigas, F; Franchini, L; Gasperini, M; Perez, J; Sforzini, L; Smeraldi, E; Zanardi, R	1
McKay, CA; Tilden, FF; Weiner, AL	1
Ewald, R; Frank, UG; Joos, AA; Kaschka, WP; König, F; Mörike, KE	1
Bigger, JT; Finkel, MS; Gaffney, A; Gergel, I; Kennedy, JS; Laghrissi-Thode, F; McCafferty, J; Narayan, M; Nelson, JC; Pollock, BG; Roose, SP	1
Benfield, P; Gunasekara, NS; Noble, S	1
Cohen, CI; Trappler, B	1
O'Connor, M; Silver, H	1
Buesching, DP; Croghan, TW; Crown, WH; Heiligenstein, JH; Hylan, TR; Melfi, CA; Meneades, L	2
Echlin, D; Hawley, CJ; McPhee, S; Pattinson, HA; Quick, SJ; Sivakumaran, T; Smith, V	1
Falkowski, J; Horton, RW; Jacobson, RR; Lawrence, KM; Lowther, S	1
Amsterdam, JD; Garcia-España, F; Goodman, D; Hooper, M; Hornig-Rohan, M	1
Fawcett, J; Mitchell, S; Zajecka, J	1
Bergam, K; Claypoole, K; Elliott, AJ; Roy-Byrne, PP; Russo, J; Uldall, KK	1
Chiu, HF; Lam, LC; Leung, VP	1
Bray, J; Hunter, BN; Katona, CL	1
Cowen, PJ; Sargent, PA; Williamson, DJ	1
Baumann, P; Bryois, C; Rubin, C; Zbinden, JD	1
Shepherd, J; Strachan, J	1
Andrews, W; Barrett, E; Parker, G	1
Bovier, P; Karege, F; Malafosse, A; Stepanian, R	1
Houck, PR; Jacobs, S; Miller, MD; Prigerson, HG; Reynolds, CF; Shear, MK; Zygmont, M	1
Baharoglu, B; Block, C; West, SA	1
Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF	1
Dunner, D; Kumar, R	1
Beach, K; Dougherty, D; Hilal, R; Nesbitt, L; Sallee, FR	1
Kaleda, VG; Khananashvili, MM; Korenev, AN; Oleĭchik, IV; Panteleeva, GP	1
Ackenheil, M; Bottlender, R; Gallinat, J; Hegerl, U; Kuss, HJ; Möller, HJ	1
Begley, AE; Kirshner, MA; Mazumdar, S; Mulsant, BH; Nebes, R; Pollock, BG; Reynolds, CF	1
Broyer, M; Chamba, G; d'Amato, T; Dalery, J; Ghaemmaghami, C; Lestra, C; Perret-Liaudet, A; Renaud, B	1
Dobmeier, P; Erfurth, A; Loew, M; Wendler, G	1
Roose, SP; Suthers, KM	1
Carlson, EJ; Carman, J; Cascieri, MA; Chicchi, GG; Cutler, N; Feighner, J; Hale, JJ; Hargreaves, RJ; Harrison, T; Hefti, F; Hewson, L; Hill, RG; Kramer, MS; Liu, G; MacCoss, M; Mills, SG; Reines, SA; Rupniak, NM; Sadowski, S; Scolnick, EM; Shrivastava, R; Smith, D; Snavely, D; Sramek, JJ; Swain, CJ; Williams, AR; Wyatt-Knowles, E	1
Gagnon, M; Layton, S; Messier, C	1
Baldassarre, P; Loriedo, C; Paolillo, A; Raccah, R; Vella, G	1
Becker, A; Frank, C; Grecksch, G; Huether, G; Pilz, J; Zhou, D	1
Pollock, BG	1
Thompson, C	2
Campo, JV; Perel, JM; Smith, C	1
Ellison, Z; Evans, CL; Fombonne, E; Ha, Y; Saisch, S	1
Baldwin, RM; Berman, R; Carpenter, L; Charney, DS; Innis, RB; Malison, RT; Nemeroff, CB; Owens, MJ; Pelton, GH; Price, LH; Rajeevan, N; Sanacora, G; Seibyl, JP; van Dyck, CH	1
Nutt, D	1
Delmeire, L; Lin, AH; Maes, M; Scharpé, S; Van der Planken, M; Van Gastel, A; Verkerk, R	1
Agren, H; Björling, G; Fahlén, T; Landén, M	1
Amsterdam, JD; Deltito, JA; Dunner, DL; Fava, M; Salzman, C; Schwaller, M	1
Buysse, DJ; Dew, MA; Kupfer, DJ; Nowell, PD; Reynolds, CF	1
Bissette, G; Fumagalli, F; McCook, EC; Miller, DB; Seidler, FJ; Slotkin, TA; Zhang, J	1
Voris, JC	1
Whittington, R; Wilde, MI	1
Bentkover, JD; Feighner, JP	1
Alvarez, E; Artigas, F; Pérez, V; Puigdemont, D; Soler, J	1
Bauer, M; Meister, W; Müller-Oerlinghausen, B; Zaninelli, R	1
Nelson, JC; Ostroff, RB	1
Derbyshire, S; Dew, MA; Houck, PR; Kupfer, DJ; Meltzer, CC; Milko, D; Nofzinger, E; Pollock, B; Reynolds, CF; Smith, GS	1
Phillips, KA; Rothschild, AJ	1
Balon, R	1
Amiaz, R; Dannon, PN; Grunhaus, L; Schreiber, S; Stein, O	1
Gergel, I; Kennedy, JS; Laghrissi-Thode, F; McCafferty, J; Narayan, M; Nelson, JC; Nobler, MS; Pollock, BG; Robin, DW; Roose, S	1
Peeters, FP; Zandbergen, J	1
Lamberg, L	1
Boyer, P	1
Blumer, JL; Branicky, L; Fiala, S; Findling, RL; Myers, C; O'Riordan, MA; Reed, MD; Waldorf, B	1
Freed, E; Goldney, R; Johnston, R; Lambert, T; Tiller, J	1
Nutt, DJ	1
Dew, MA; Green, TD; Houck, PR; Kupfer, DJ; Mazumdar, S; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Carleborg, L; Hägg, S; Ohman, R; Spigset, O	1
Connor, KM; Davidson, JR	1
Galin, RS; Robison, LM; Sclar, DA; Skaer, TL	1
Bensasi, S; Houck, PR; Little, JT; Mazumdar, S; Miller, MD; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Stack, J	1
Mulsant, BH; Pollock, BG; Reynolds, CF; Walters, G	1
Butters, MA; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Zmuda, MD	1
Roose, SP; Spatz, E	1
Berndt, ER; Colucci, S; Grudzinski, AN; Miceli, R; Russell, JM	1
Kraus, JE	1
Alvarez, JC; Arnulf, I; Gluck, N; Launay, JM; Leboyer, M; Pecquery, R; Perez-Diaz, F; Quintin, P; Spreux-Varoquaux, O	1
Baker, F; Day, A; Gath, DH; Mynors-Wallis, LM	1
Boyer, P; Poirier, MF	1
Cohen, LS; Hostetter, A; Nemeroff, CB; Owens, MJ; Ritchie, JC; Stowe, ZN	1
Angersbach, D; Hackl, HJ; Leucht, S; Steimer, W; Zimmer, R	1
Amsterdam, J; Apter, J; Fava, M; Londborg, P; Michelson, D; Pagh, L; Tamura, R	1
Blier, P; de Montigny, C; Haddjeri, N; Szabo, ST	1
Ashton, AK	1
Connor, TJ; Harkin, A; Kelliher, P; Kelly, JP; Leonard, BE; Shen, Y	1
Laghrissi-Thode, F; Pollock, BG; Wagner, WR	1
Antonietti, M; Denis, P; Ducrotte, P; Lalaude, O; Leroi, AM; Menard, JF; Touchais, JY	1
Farmer, AE; Malhi, GS	1
Contu, A; Gutschow, K; Möslinger-Gehmayr, R; Oberhoff, C; Schindler, AE; Staab, HJ; Zaninelli, R	1
Fagan, M	1
Ascher, JA; Batey, SR; Donahue, RM; Houser, TL; Settle, EC; Weihs, KL	1
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL	1
Goodnick, PJ; Kumar, AM	1
Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH	1
Ballús, C; Casais, L; De Flores, T; de la Torre, J; Gutiérrez, M; Palao, D; Quiros, G; Riesgo, Y; Rojo, L	1
Fava, M; Hoog, SL; Kopp, JB; Nilsson, ME; Rosenbaum, JF; Tepner, RG	1
Alborzian, S; Baxter, LR; Brody, AL; Demaree, HA; Fairbanks, LA; Maidment, KM; Saxena, S	1
Balraj, E; Bligh-Glover, W; Dilley, GE; Friedman, L; Kolli, TN; Rajkowska, G; Shapiro-Kulnane, L; Stockmeier, CA	1
Dorevitch, A; Sella, A; Umansky, L	1
Healy, E; McKeon, P	1
Bassanelli, AG; Naughton, BJ; Ramadan, FH	1
Kirsch, MA; Louie, AK	1
Berreira, PJ; Cohen, BM; Henry, ME; Kaufman, MJ; Michelson, D; Moore, CM; Renshaw, PF; Schmidt, ME; Stoddard, E; Vuckevic, AJ	1
Baier, D; Kohnen, R; Philipp, M; Tiller, JW	1
Bongiorno, F; Franchini, L; Rossini, D; Smeraldi, E; Spagnolo, C; Zanardi, R	1
Baron, A; Hanson, SR; Knight, BT; Manatunga, A; Marzec, UM; Musselman, DL; Nemeroff, CB; Penna, S; Reemsnyder, A	1
Avci, A; Diler, RS; Tamam, L	1
Davis, S; Ferrell, RE; Houck, PR; Kirshner, MA; Kupfer, DJ; Mazumdar, S; Miller, M; Mulsant, BH; Pollock, BG; Reynolds, CF; Stack, JA; Sweet, RA	1
Benkert, O; Kohnen, R; Szegedi, A	1
Bellini, G; Bonuccelli, U; Ceravolo, R; Dell'Agnello, G; Dell'Osso, L; Gambaccini, G; Murri, L; Nuti, A; Piccinni, A	1
Becker, JT; Butters, MA; Mulsant, BH; Nebes, RD; Pollock, BG; Reynolds, CF; Zmuda, MD	1
Fava, M; Hoog, SL; Judge, R; Koke, SC; Nilsson, ME	1
Brown, GM; DaSilva, J; Eisfeld, B; Houle, S; Kapur, S; Kennedy, SH; Mayberg, HS; Meyer, JH; Rafi-Tari, S; Wilson, AA	1
Haddad, PM; Qureshi, M	1
Caputo, RM; Stern, S; Votolato, NA	1
Bourin, M; David, DJ; Hascoët, M; Jolliet, P; Nic Dhonnchadha, BA	1
Fitzgerald, F; Glod, CA; Lynch, A	1
Hull, JG; Oxman, TE	1
Weintrob, A	1
Deahl, M	1
Blier, P; Culpepper, L; Gorman, JM; Hirschfeld, RM; Leon, AC; Nierenberg, AA; Roose, SP; Rosenbaum, JF; Stahl, SM; Trivedi, MH	1
Aberg-Wistedt, A; Khoury, AE; Stain-Malmgren, R; Tham, A	1
Erfurth, A; Floreanu, A; Loew, M; Wendler, G	1
Hansen, L; Wilkinson, DG	1
Colla, M; Dempfle, CE; Deuschle, M; Heuser, I; Lederbogen, F; Weber, B	1
Colla, M; Deuschle, M; Gernoth, C; Heuser, I; Kniest, A; Lederbogen, F; Weber, B	1
Goodkin, RS; Greiner, K; Gumnick, JF; Lawson, DH; Manatunga, AK; Miller, AH; Musselman, DL; Nemeroff, CB; Penna, S	1
Couvée, JE; Zitman, FG	1
Kaschka, WP; König, F; Neuhöffer-Weiss, M; Petersdorff, T; von Hippel, C; Wolfersdorf, M	1
Schouten, WE; Sepers, JM	1
Panzarino, PJ; Xuan, J	1
Arifuzzman, AI; Evans, KR; Houle, S; Kennedy, SH; Krüger, S; Mayberg, HS; McCann, S; Meyer, JH; Vaccarino, FJ	1
Kremer, C; Quitkin, FM; Taylor, BP	1
Klein, RM; Walker, JB; Yee, SL	1
Baerg, EA; Garland, EJ	1
Birmaher, B; Carlson, GA; Clarke, GN; Emslie, GJ; Feinberg, D; Geller, B; Hagino, OR; Keller, MB; Klein, RG; Koplewicz, H; Kusumakar, V; Kutcher, SP; McCafferty, JP; Oakes, R; Papatheodorou, G; Ryan, ND; Sack, WH; Strober, M; Sweeney, M; Wagner, KD; Weller, EB; Winters, NC	1
Alborzian, S; Au, SC; Baxter, LR; Brody, AL; Fairbanks, LA; Gillies, LA; Ho, MK; Ho, ML; Huang, SC; Maidment, K; Phelps, ME; Saxena, S; Stoessel, P; Wu, HM	1
Kraus, MR; Schäfer, A; Scheurlen, M	1
Baruch, Y; Chelben, J; Lustig, M; Strous, RD	1
Dulchin, MC; Ellis, SP; Li, S; Malone, KM; Mann, JJ; Oquendo, MA	1
Ramasubbu, R	1
Armani, A; Baroni, S; Cassano, GB; Dell'Osso, L; Di Nasso, E; Giannaccini, G; Lucacchini, A; Marazziti, D; Masala, I; Rossi, A	1
Buysse, DJ; Fagiolini, A; Frank, E; Houck, PR; Kupfer, DJ; Luther, JF	1
Cusin, C; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R	1
Dolor, R; Eckert, GJ; Gilsenan, A; Hays, R; Kroenke, K; Stang, P; Swindle, R; Weinberger, M; West, SL; Zhou, XH	1
Azoulay, P; Septien, L; Waintraub, L	1
Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S	1
Cassano, GB; Jori, MC	1
Bauer, MS; Glick, HA; Onesirosan, P; Polsky, D	1
Baumann, P; Begré, S; Cosendai-Savary, L; Eap, CB; Golay, KP; Jaquet-Rochat, S; Kosel, M; Ladewig, D; von Bardeleben, U	1
Cronholm, P; Straton, JB	1
Grunze, H; Hörn, M; Hummel, B; Normann, C; Schärer, LO; Walden, J	1
Burrows, AB; Gersh, T; Noble, K; Pollock, BG; Salzman, C; Satlin, A	1
Bakker, A; Vergouwen, AC	1
Cassano, GB; Puca, F; Scapicchio, PL; Trabucchi, M	1
Cheer, SM; Goa, KL; Matheson, AJ; Ormrod, D; Wagstaff, AJ	1
Csef, H; Faller, H; Kraus, MR; Schäfer, A; Scheurlen, M	1
Argyropoulos, SV; Bell, CJ; Edwards, C; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, SJ	1
Culpepper, L	1
Cusin, C; Lattuada, E; Lilli, R; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R	1
Fujii, A; Kaneda, Y; Kawamura, I; Ohmori, T	1
Dew, MA; Frank, E; Gildengers, AG; Houck, PR; Kupfer, DJ; Mazumdar, S; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Azaz-Livshits, T; Ben-Chetrit, E; Hershko, A	1
Bech, P; Lauritzen, L; Lunde, M; Mellerup, ET; Plenge, P	1
Johnson, AM	1
Block, P; Fieve, RR; Peselow, ED; Robins, CJ; Sanfilipo, MP	1
Dunbar, GC; Fuell, DL; Sheehan, D	1
Difiglia, C; Fieve, RR; Peselow, ED; Sanfilipo, MP	1
Claghorn, J	1
Feighner, JP	1
Clarke, A; Hutchinson, DR; Moon, CA; Tong, S; Vince, M	1
Bignamini, A; Rapisarda, V	1
Dorman, T	1
Lewis, Y; Warrington, SJ	1
Hindmarch, I	1
Jenner, PN	1
Dunbar, GC; Fuell, DL	1
Montgomery, SA	2
Grimsley, SR; Jann, MW	1
Bahr, B; Borup, A; Calberg, H; Christiansen, PE; Larsen, SB; Loldrup, D; Nilakantan, B; Ohrberg, S; Severin, B; Søgaard, J	1
Dunbar, GC; Stoker, MJ; Tignol, J	1
DeVane, CL	1
Dunbar, GC; Dunner, DL	1
Kiev, A	1
Boyer, WF; Feighner, JP	3
Amsterdam, J; Clary, C; Fox, I; Rickels, K; Schweizer, E; Weise, C	2
Claghorn, JL	1
Glaudin, V; Smith, WT	1
Fabre, LF	1
Blumhardt, CL; Overweg, N; Shrivastava, RK; Shrivastava, SH	1
Cohn, JB; Wilcox, CS	1
Cohn, CK; Cohn, JB; Dunner, DL; Feighner, JP; Fieve, RR; Halikas, JP; Hartford, JT; Hearst, ED; Settle, EC; Walshe, T	1
Blumhardt, CL; Boyer, WF	1
Johnson, AM; Tulloch, IF	1
Goodman, WK; McDougle, CJ; Price, LH	1
Kuhs, H; Rolf, LH; Rudolf, GA; Schlake, HP	1
Clissold, SP; Dechant, KL	1
Bengtsson, BO; Lundmark, J; Wålinder, J	1
Larsen, T; Manniche, PM; Morsing, I; Møller, SE; Nielsen, OA; Petersen, JS; Skausig, OB	1
Briley, M; Moret, C	1
Baldwin, D; Bullock, T; Montgomery, D; Montgomery, S	1
Bech, P; Bjerrum, H; Butler, B; Bøjholm, S; Folker, H; Gram, LF; Larsen, JK; Lauritzen, L; Loldrup, D; Møller, SE	1
Cheetham, SC; Crompton, MR; De Paermentier, F; Horton, RW; Katona, CL; Lawrence, KM	3
Cohn, JB; Crowder, JE; Ryan, PJ; Wilcox, CS	1
Rickels, K; Schweizer, E	1
Mellerup, ET; Plenge, P	1
Edwards, JG; Goldie, A; Papayanni-Papasthatis, S; Punter, J; Sedgwick, EM	1
Lassen, JB	1
Fourie, J; Gagiano, CA; Le Roux, JF; Müller, PG	1
Archambault, JC; Chabannes, JP; Clerc, G; Desvilles, M; Guibert, M; Guillibert, E; Pagot, R; Pelicier, Y; Poisat, JL; Thobie, Y	1
Byrne, MM	1
Mertens, C; Pintens, H	2
Bascara, L	1
Miller, SM; Murtagh, M; Naylor, GJ; Winslow, G	1
Kuhs, H; Rudolf, GA	1
Brune, GG; Husstedt, IW; Kuhs, H; Rudolf, GA	1
Bosse, T; Brune, GG; Kuhs, H; Rolf, LH; Rudolf, GA; Schlake, HP; Schuhknecht, E	1
Kaye, CM; Link, CG; Tasker, TC; Zussman, BD	1
Greb, WH; Haddock, RE; Kaye, CM; Langley, PF; Mellows, G; Tasker, TC; Zussman, BD	1
Fjord-Larsen, T; Lundmark, J; Manniche, PM; Mengel, H; Møller-Nielsen, EM; Pauser, H; Scheel Thomsen, I; Wålinder, J	1
Dunbar, GC; Fellerer, K; Hebenstreit, GF; Zentz, A; Zöchling, R	1
Ghose, K	1
Barouche, F; Fieve, RR; Filippi, AM; Goodnick, P; Peselow, ED	2
Barouche, F; Fieve, RR; Filippi, AM; Goodnick, P; Peselow, ED; Stanley, M	1
Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A	1
D'haenen, H; De Waele, M; Leysen, JE	1
Barnas, C; Fleischhacker, WW; Hinterhuber, H; Mair, M; Schifferle, I; Schubert, H; Stuppäck, C; Unterweger, B; Wömhart, L	1
Galzin, AM; Langer, SZ; Loo, H; Poirier, MF; Sechter, D; Zarifian, E	1
Laursen, AL; le Fèvre Honoré, P; Mikkelsen, PL; Rasmussen, S	1
Battegay, R; Hager, M; Rauchfleisch, U	1

Reviews

85 review(s) available for paroxetine and Depressive Disorder

Article	Year
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review. Acta psychiatrica Scandinavica, 2020, Volume: 141, Issue:1 Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors	2020
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain. PloS one, 2020, Volume: 15, Issue:12 Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome	2020
Paroxetine-Overview of the Molecular Mechanisms of Action. International journal of molecular sciences, 2021, Feb-07, Volume: 22, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Paroxetine; Serotonin Antagonists	2021
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression. Acta psychiatrica Scandinavica, 2017, Volume: 136, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Anxiety; Citalopram; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sertraline	2017
Advances in Pharmacotherapy of Late-Life Depression. Current psychiatry reports, 2018, 04-07, Volume: 20, Issue:5 Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine	2018
Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials. Medicine, 2019, Volume: 98, Issue:22 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cardiovascular Diseases; China; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2019
Antidepressant use in pregnant and postpartum women. Annual review of clinical psychology, 2014, Volume: 10 Topics: Antidepressive Agents; Depression, Postpartum; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects	2014
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression. BMC psychiatry, 2014, Aug-27, Volume: 14 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; China; Citalopram; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2014
A Novel Methodology to Estimate the Treatment Effect in Presence of Highly Variable Placebo Response. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:11 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Linear Models; Models, Psychological; Paroxetine; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome	2015
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Controlled Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Risk; Selective Serotonin Reuptake Inhibitors	2009
[Indications for crenotherapy]. L'Encephale, 2009, Volume: 35 Suppl 4 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Asthenia; Balneology; Complementary Therapies; Depressive Disorder; Humans; Mental Disorders; Multicenter Studies as Topic; Paroxetine; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Somatoform Disorders	2009
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. L'Encephale, 2010, Volume: 36 Suppl 2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Secondary Prevention; Selective Serotonin Reuptake Inhibitors	2010
Gender differences in antidepressant drug response. International review of psychiatry (Abingdon, England), 2010, Volume: 22, Issue:5 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression, Postpartum; Depressive Disorder; Drug Tolerance; Female; Humans; Male; Milk, Human; Paroxetine; Pregnancy; Prevalence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Women	2010
Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues. Drug safety, 2011, Nov-01, Volume: 34, Issue:11 Topics: Depressive Disorder; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2011
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Current medicinal chemistry, 2012, Volume: 19, Issue:12 Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride	2012
Newer generation antidepressants for depressive disorders in children and adolescents. The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Induction Chemotherapy; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide	2012
Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Bias; Causality; Compensation and Redress; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Drug Utilization; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Product Surveillance, Postmarketing; Publishing; Risk Factors; Selective Serotonin Reuptake Inhibitors	2012
Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:2 Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Depressive Disorder; Female; Humans; Infant, Newborn; Paroxetine; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Risk Factors; Selective Serotonin Reuptake Inhibitors	2013
Depression and anxiety in oncology: the psychiatrist's perspective. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 8 Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Humans; Medical Oncology; Neoplasms; Paroxetine; Personality Inventory; Prevalence; Psychiatric Status Rating Scales; Psychiatry; Risk Factors; Selective Serotonin Reuptake Inhibitors	2001
An overview of the clinical efficacy of mirtazapine. Human psychopharmacology, 2002, Volume: 17 Suppl 1 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2002
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biological psychiatry, 2002, Dec-15, Volume: 52, Issue:12 Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride	2002
Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Human psychopharmacology, 2003, Volume: 18, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2003
[The "Sisi syndrome": a new form of depression?]. Der Nervenarzt, 2003, Volume: 74, Issue:5 Topics: Advertising; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Industry; Germany; Humans; Marketing; Paroxetine; Syndrome	2003
Paroxetine treatment of depression in late life. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Aged; Antidepressive Agents, Second-Generation; Cognition Disorders; Delayed-Action Preparations; Depressive Disorder; Humans; Paroxetine; Suicide Prevention	2003
Improving antidepressant adherence. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 18 Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Health Promotion; Humans; Paroxetine; Patient Compliance; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride	2003
Paroxetine controlled release. CNS drugs, 2004, Volume: 18, Issue:6 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Delayed-Action Preparations; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Odds Ratio; Paroxetine; Practice Guidelines as Topic; Premenstrual Syndrome; Psychiatric Status Rating Scales	2004
Paroxetine-related tremor. Geriatrics, 2005, Volume: 60, Issue:7 Topics: Aged; Aged, 80 and over; Contraindications; Depressive Disorder; Female; Geriatrics; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tremor	2005
Posttraumatic stress disorder: a state-of-the-science review. Journal of psychiatric research, 2006, Volume: 40, Issue:1 Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cross-Sectional Studies; Depressive Disorder; Hippocampus; Humans; Life Change Events; Paroxetine; Risk Factors; Stress Disorders, Post-Traumatic	2006
Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Cohort Studies; Depressive Disorder; Ethnicity; Female; Humans; Male; Middle Aged; Minority Groups; Nausea; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Survival Analysis; Treatment Outcome	2005
Pharmacologic treatment of acute and chronic stress following trauma: 2006. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 2 Topics: Algorithms; Anxiety Disorders; Comorbidity; Depressive Disorder; Disasters; Drug Administration Schedule; Humans; Internet; Paroxetine; Psychotropic Drugs; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Survivors; Treatment Outcome	2006
Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder. Psychopharmacology, 2006, Volume: 188, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Duloxetine Hydrochloride; Europe; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; United States	2006
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted	2006
SSRIs and the syndrome of inappropriate antidiuretic hormone secretion. The American journal of nursing, 2007, Volume: 107, Issue:1 Topics: Aged, 80 and over; Brain; Critical Care; Depressive Disorder; Drug Monitoring; Heart; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Male; Multiple Trauma; Paroxetine; Risk Factors; Saline Solution, Hypertonic; Selective Serotonin Reuptake Inhibitors; Sodium; Sodium Chloride; Sodium Potassium Chloride Symporter Inhibitors	2007
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. The Cochrane database of systematic reviews, 2007, Jul-18, Issue:3 Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide	2007
Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis. Psychotherapy and psychosomatics, 2008, Volume: 77, Issue:1 Topics: Adult; Analgesics; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Duloxetine Hydrochloride; Humans; Pain; Pain Measurement; Paroxetine; Psychophysiologic Disorders; Randomized Controlled Trials as Topic; Somatoform Disorders; Thiophenes; Treatment Outcome	2008
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy. Pharmacology, 1995, Volume: 51, Issue:3 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1995
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. International clinical psychopharmacology, 1995, Volume: 10 Suppl 1 Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism	1995
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6 Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1995
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:12 Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1994
Guidelines for the long-term treatment of depression. The Journal of clinical psychiatry, 1994, Volume: 55 Suppl Topics: Adult; Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Middle Aged; Paroxetine; Placebos; Psychotherapy; Recurrence; Time Factors; Treatment Outcome	1994
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline. International clinical psychopharmacology, 1994, Volume: 9 Suppl 3 Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Half-Life; Humans; Metabolic Clearance Rate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1994
An overview of paroxetine in the elderly. Gerontology, 1994, Volume: 40 Suppl 1 Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Humans; Paroxetine	1994
Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6 Suppl 2 Topics: Adolescent; Adult; Aged; Animals; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence	1993
Current issues in the treatment of major depression. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Bipolar Disorder; Chronic Disease; Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Incidence; Male; Middle Aged; Paroxetine; United States	1993
Paroxetine: a selective serotonin reuptake inhibiting antidepressant. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:10 Topics: Aged; Antidepressive Agents; Depressive Disorder; Drug Interactions; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	1993
Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression. Connecticut medicine, 1993, Volume: 57, Issue:9 Topics: Depressive Disorder; Drug Interactions; Humans; Paroxetine	1993
Management of recurrent depression. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline	1993
Use of serotonin selective reuptake inhibitors in geriatric depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5 Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
Depression: making the diagnosis and using SSRIs in the older patient. Geriatrics, 1996, Volume: 51, Issue:10 Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1996
Movement disorders associated with the serotonin selective reuptake inhibitors. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10 Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States	1996
Antidepressant discontinuation: a review of the literature. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs, 1998, Volume: 55, Issue:1 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Nausea; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case]. Praxis, 1998, Mar-04, Volume: 87, Issue:10 Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998
Paroxetine: a review of clinical experience. Pharmacopsychiatry, 1998, Volume: 31, Issue:3 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Paroxetine	1998
Antidepressant response in late-life depression. The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10 Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1998
Paroxetine. A pharmacoeconomic evaluation of its use in depression. PharmacoEconomics, 1995, Volume: 8, Issue:1 Topics: Antidepressive Agents, Second-Generation; Cost of Illness; Depressive Disorder; Humans; Paroxetine	1995
Mirtazapine versus selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17 Topics: Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Care of depressed patients with anxiety symptoms. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17 Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Citalopram; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Management of posttraumatic stress disorder: diagnostic and therapeutic issues. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 18 Topics: Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Depressive Disorder; Diagnosis, Differential; Humans; Life Change Events; Paroxetine; Psychotherapy; Psychotropic Drugs; Stress Disorders, Post-Traumatic; Substance-Related Disorders	1999
Treatment of depression in patients with heart disease. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Comorbidity; Death, Sudden; Depressive Disorder; Double-Blind Method; Heart Block; Heart Diseases; Humans; Hypotension, Orthostatic; Myocardial Ischemia; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ventricular Fibrillation	1999
Psychopharmacologic treatment of adolescent depression. Archives of psychiatric nursing, 2001, Volume: 15, Issue:1 Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride	2001
Pharmacological treatment of depression: the role of paroxetine. Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder; Drug Interactions; Female; Humans; Intestinal Absorption; Male; Paroxetine; Randomized Controlled Trials as Topic; Treatment Outcome	2001
Spotlight on paroxetine in psychiatric disorders in adults. CNS drugs, 2002, Volume: 16, Issue:6 Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2002
Generalized anxiety disorder in primary care: emerging issues in management and treatment. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 8 Topics: Adaptation, Psychological; Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Physicians, Family; Prevalence; Primary Health Care; Recurrence; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; United States; Venlafaxine Hydrochloride	2002
Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature. Pharmacopsychiatry, 2002, Volume: 35, Issue:3 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Depressive Disorder; Humans; Male; Middle Aged; Paroxetine; Risk Factors	2002
Paroxetine: a pharmacological review. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Animals; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Receptors, Neurotransmitter	1992
Melancholic/endogenous depression and response to somatic treatment and placebo. The American journal of psychiatry, 1992, Volume: 149, Issue:10 Topics: Antidepressive Agents; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	1992
Cardiovascular effects of antidepressants: studies of paroxetine in healthy men and depressed patients. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Blood Pressure; Cardiovascular System; Depressive Disorder; Female; Heart Rate; Humans; Male; Paroxetine	1992
A review of the psychomotor effects of paroxetine. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Adult; Aged; Aging; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychomotor Performance	1992
Paroxetine: an overview of dosage, tolerability, and safety. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine	1992
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clinical pharmacy, 1992, Volume: 11, Issue:11 Topics: 1-Naphthylamine; Depressive Disorder; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1992
Paroxetine in the treatment of melancholia and severe depression. International clinical psychopharmacology, 1992, Volume: 7, Issue:2 Topics: Adult; Depression; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1992
Pharmacokinetics of the selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline	1992
Optimal dose regimen for paroxetine. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Administration, Oral; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Multicenter Studies as Topic; Paroxetine; Piperidines	1992
An overview of paroxetine. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Humans; Nausea; Paroxetine; Piperidines; Serotonin Antagonists	1992
The safety profile of paroxetine. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Cardiovascular System; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Electrocardiography; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Psychomotor Performance; Sleep	1992
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline	1992
Pharmacotherapy of obsessive compulsive disorder. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline	1992
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs, 1991, Volume: 41, Issue:2 Topics: Amitriptyline; Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Evaluation; Drug Tolerance; Humans; Imipramine; Paroxetine; Piperidines; Serotonin Antagonists	1991
5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour. International clinical psychopharmacology, 1991, Volume: 6 Suppl 3 Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Mianserin; Paroxetine; Piperidines; Serotonin Antagonists; Suicide; Suicide Prevention	1991
Clinical overview of serotonin reuptake inhibitors. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl B Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine	1990
New antidepressants and 5-HT uptake inhibitors. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Depressive Disorder; Humans; Long-Term Care; Paroxetine; Piperidines; Serotonin Antagonists	1989
A review of the metabolism and pharmacokinetics of paroxetine in man. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Depressive Disorder; Drug Interactions; Humans; Metabolic Clearance Rate; Paroxetine; Piperidines; Serotonin Antagonists	1989
Therapeutic effects of serotonin uptake inhibitors in depression. The Journal of clinical psychiatry, 1986, Volume: 47 Suppl Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine	1986

Trials

241 trial(s) available for paroxetine and Depressive Disorder

Article	Year
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:12 Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2021
Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance. Journal of anxiety disorders, 2017, Volume: 52 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Paroxetine; Phobia, Social; Treatment Outcome	2017
Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chi-Square Distribution; Depressive Disorder; Drug Administration Schedule; Female; Humans; Italy; Male; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome	2013
SSRI-related modulation of sexual functioning is predicted by pre-treatment resting state functional connectivity in healthy men. Archives of sexual behavior, 2013, Volume: 42, Issue:6 Topics: Adult; Brain; Cross-Over Studies; Depressive Disorder; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological	2013
A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology, 2009, Mar-10, Volume: 72, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep; Social Behavior; Treatment Outcome	2009
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:3 Topics: Adolescent; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Personality Inventory; Prognosis; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2009
Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy. Journal of psychiatric research, 2009, Volume: 43, Issue:12 Topics: Antidepressive Agents, Second-Generation; Databases, Bibliographic; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Severity of Illness Index; Time Factors; Treatment Outcome	2009
History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Aug-31, Volume: 33, Issue:6 Topics: Adult; Anxiety Disorders; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain Measurement; Paroxetine; Predictive Value of Tests; Treatment Outcome	2009
Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI. Journal of sex & marital therapy, 2009, Volume: 35, Issue:4 Topics: Adrenergic Agents; Adult; Arousal; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Ephedrine; Female; Fluoxetine; Humans; Norepinephrine; Orgasm; Paroxetine; Premedication; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Behavior; Sexual Dysfunction, Physiological; Sympathetic Nervous System	2009
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. Journal of sleep research, 2009, Volume: 18, Issue:3 Topics: Adult; Affect; Algorithms; Antidepressive Agents, Second-Generation; Delta Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monitoring, Ambulatory; Paroxetine; Piperazines; Signal Processing, Computer-Assisted; Sleep; Sleep, REM; Treatment Outcome; Triazoles	2009
Depression and comorbid panic in primary care patients. Journal of affective disorders, 2010, Volume: 123, Issue:1-3 Topics: Adult; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Panic Disorder; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States	2010
Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine. Current medical research and opinion, 2010, Volume: 26, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Time Factors	2010
Early telephone intervention for psychiatric outpatients starting antidepressant treatment. Nordic journal of psychiatry, 2010, Volume: 64, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Motivation; Outpatients; Paroxetine; Patient Compliance; Severity of Illness Index; Social Support; Switzerland; Telemedicine; Telephone; Treatment Outcome; Young Adult	2010
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 2010,Spring, Volume: 22, Issue:2 Topics: Adult; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Parkinson Disease; Paroxetine; Time Factors; Treatment Outcome	2010
The influence of personality factors on paroxetine response time in patients with major depression. Journal of affective disorders, 2011, Volume: 135, Issue:1-3 Topics: Adult; Aged; Antidepressive Agents; Character; Depression; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Personality; Personality Disorders; Personality Inventory; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Temperament; Treatment Outcome	2011
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology, 2012, Apr-17, Volume: 78, Issue:16 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride	2012
Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:7 Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Paroxetine; Patient Dropouts; Placebos; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome	2002
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. International clinical psychopharmacology, 2002, Volume: 17, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Behavior; Substance Withdrawal Syndrome	2002
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:3 Topics: Adult; Attention; Cross-Over Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:5 Topics: Adrenergic Agents; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Debrisoquin; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Time Factors	2002
Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. The American journal of psychiatry, 2002, Volume: 159, Issue:10 Topics: Adult; Ambulatory Care; Carrier Proteins; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Treatment Outcome	2002
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. The American journal of psychiatry, 2002, Volume: 159, Issue:10 Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome	2002
Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia. Human psychopharmacology, 2002, Volume: 17, Issue:4 Topics: Aged; Aged, 80 and over; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Fluoxetine; Genotype; Humans; Hyponatremia; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors	2002
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. International clinical psychopharmacology, 2003, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Paroxetine; Placebos; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide. International clinical psychopharmacology, 2003, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2003, Volume: 42, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Child; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Logistic Models; Male; Paroxetine; Patient Compliance; Safety; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric	2003
The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:7-8 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Biomarkers; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Predictive Value of Tests; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Thiazepines; Treatment Outcome	2002
Clinical experience with substance P receptor (NK1) antagonists in depression. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 11 Topics: Antidepressive Agents; Anxiety Disorders; Aprepitant; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Ethers; Female; Humans; Hydrocarbons, Fluorinated; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance P; Treatment Outcome	2002
[3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. International journal of immunopharmacology, 1999, Volume: 21, Issue:10 Topics: Adult; Cell Membrane; Depressive Disorder; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Lymphocytes; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin	1999
Onset of major depression during treatment for nicotine dependence. Addictive behaviors, 2003, Volume: 28, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder	2003
A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. International clinical psychopharmacology, 2003, Volume: 18, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Fatigue; Female; Headache; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Paroxetine; Primary Health Care; Severity of Illness Index; Sweating; Treatment Outcome	2003
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Prognosis; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome	2003
Occurrence and course of suicidality during short-term treatment of late-life depression. Archives of general psychiatry, 2003, Volume: 60, Issue:6 Topics: Aged; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Nortriptyline; Paroxetine; Psychotherapy; Risk Factors; Severity of Illness Index; Suicide; Suicide, Attempted; Time Factors; Treatment Outcome	2003
Good treatment outcomes in late-life depression with comorbid anxiety. Journal of affective disorders, 2003, Volume: 77, Issue:3 Topics: Age of Onset; Aged; Aged, 80 and over; Aging; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Prognosis; Psychotherapy; Treatment Outcome	2003
Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder. Yonsei medical journal, 2004, Feb-29, Volume: 45, Issue:1 Topics: Adolescent; Cerebrovascular Circulation; Child; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon	2004
The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care. International clinical psychopharmacology, 2004, Volume: 19, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Primary Health Care; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Treatment Outcome	2004
Paroxetine treatment of depression with posttraumatic stress disorder: effects on autonomic reactivity and cortisol secretion. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:2 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Autonomic Nervous System; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Neurosecretory Systems; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Stress Disorders, Post-Traumatic; Treatment Outcome	2004
The outcome of physical symptoms with treatment of depression. Journal of general internal medicine, 2004, Volume: 19, Issue:8 Topics: Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Status; Health Surveys; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Treatment Outcome	2004
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. International clinical psychopharmacology, 2004, Volume: 19, Issue:5 Topics: Acetamides; Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2004
The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: assessment of its evaluative properties over the course of a 16-week pediatric psychopharmacotherapy trial. Journal of child and adolescent psychopharmacology, 2004,Summer, Volume: 14, Issue:2 Topics: Adolescent; Aging; Antidepressive Agents, Second-Generation; Anxiety; Child; Depressive Disorder; Double-Blind Method; Female; Humans; Interpersonal Relations; Male; Paroxetine; Phobic Disorders; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sex Characteristics; Treatment Outcome	2004
Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10 Topics: Adult; Delayed-Action Preparations; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Patient Dropouts; Placebos; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2004
Open-label non-randomized versus double-blind randomized antidepressive treatment: what are the advantages of clinical decision over randomization? Pharmacopsychiatry, 2004, Volume: 37, Issue:6 Topics: Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome	2004
Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine. Human psychopharmacology, 2004, Volume: 19, Issue:8 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclopropanes; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Milnacipran; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome	2004
Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ (Clinical research ed.), 2005, Mar-05, Volume: 330, Issue:7490 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Phytotherapy; Plant Extracts; Treatment Outcome	2005
Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of general psychiatry, 2005, Volume: 62, Issue:4 Topics: Adult; Ambulatory Care; Antidepressive Agents; Cognitive Behavioral Therapy; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2005
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of general psychiatry, 2005, Volume: 62, Issue:4 Topics: Adult; Ambulatory Care; Antidepressive Agents; Cognitive Behavioral Therapy; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Nutrition Surveys; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Secondary Prevention; Severity of Illness Index	2005
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism. International clinical psychopharmacology, 2005, Volume: 20, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Fluvoxamine; Genotype; Heterozygote; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Patient Dropouts; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2005
Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neuroscience letters, 2005, Nov-25, Volume: 389, Issue:1 Topics: Adult; Depressive Disorder; Female; Gene Expression Regulation; Humans; Leukocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2005
Effects of paroxetine and venlafaxine XR on heart rate variability in depression. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2005
Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? The Australian and New Zealand journal of psychiatry, 2005, Volume: 39, Issue:9 Topics: Adult; Antidepressive Agents; Anxiety Disorders; Child; Child Abuse; Combined Modality Therapy; Comorbidity; Depressive Disorder; Follow-Up Studies; Humans; Irritable Bowel Syndrome; Middle Aged; Outcome and Process Assessment, Health Care; Pain Measurement; Paroxetine; Patient Care Team; Personality Assessment; Personality Inventory; Psychoanalytic Therapy; Psychometrics; Psychophysiologic Disorders; Referral and Consultation; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome	2005
Antidepressant treatment outcomes of psychogenic movement disorder. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12 Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; Comorbidity; Conversion Disorder; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypochondriasis; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride	2005
[The impact of antidepressive therapy on work productivity and life satisfaction--a one-year follow-up study]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2005, Volume: 7, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder; Efficiency; Employment; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personal Satisfaction; Product Surveillance, Postmarketing; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Work	2005
One-year outcomes of a randomized clinical trial treating depression in low-income minority women. Journal of consulting and clinical psychology, 2006, Volume: 74, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Minority Groups; Paroxetine; Patient Education as Topic; Poverty; Psychotherapy, Group	2006
Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling. British journal of clinical pharmacology, 2006, Volume: 61, Issue:5 Topics: Age Factors; Aged; Body Weight; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Genotype; Humans; Male; Nonlinear Dynamics; Paroxetine; Polymerase Chain Reaction; Racial Groups; Selective Serotonin Reuptake Inhibitors; Sex Factors	2006
Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic. Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:5 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Benzodiazepines; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Internal Medicine; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome	2006
[Clinical observation on treatment of melancholia by acupuncture following principle of relieving depression and regulating mentality]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:2 Topics: Acupuncture Therapy; Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Electroacupuncture; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome	2007
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid	2007
Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jun-30, Volume: 31, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cyclopropanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2007
Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea. The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Female; Genetic Predisposition to Disease; Humans; Incidence; Japan; Male; Middle Aged; Nausea; Paroxetine; Polymorphism, Genetic; Receptors, Serotonin, 5-HT3; Risk Factors; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2008
Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition. Journal of medicine, 2004, Volume: 35, Issue:1-6 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Menopause; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. The British journal of psychiatry : the journal of mental science, 2008, Volume: 192, Issue:2 Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Humans; Paroxetine; Personality Disorders; Treatment Outcome	2008
Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry, 2008, Volume: 41, Issue:2 Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Depressive Disorder; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Nerve Growth Factor; Paroxetine; Psychiatric Status Rating Scales; Saliva	2008
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:13 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Brain; Brain Chemistry; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nordefrin; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Venlafaxine Hydrochloride; Young Adult	2008
A controlled evaluation of monthly maintenance interpersonal psychotherapy in late-life depression with varying levels of cognitive function. International journal of geriatric psychiatry, 2008, Volume: 23, Issue:11 Topics: Aged; Antidepressive Agents, Second-Generation; Cognition; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Quality of Life; Secondary Prevention; Time Factors	2008
Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep, 1995, Volume: 18, Issue:6 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Electroencephalography; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep, REM; Wakefulness	1995
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. The American journal of psychiatry, 1995, Volume: 152, Issue:10 Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological	1995
Platelet binding characteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1995, Volume: 12, Issue:4 Topics: Adult; Biomarkers; Blood Platelets; Depressive Disorder; Female; Humans; Iodine Radioisotopes; Lysergic Acid Diethylamide; Male; Paroxetine; Placebos; Psychiatric Status Rating Scales; Receptors, Serotonin; Regression Analysis	1995
Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Pharmacopsychiatry, 1995, Volume: 28, Issue:2 Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Delusions; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1995
A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:4 Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Humans; Incidence; Male; Paroxetine; Placebos; Substance Withdrawal Syndrome; Time Factors	1995
Are selective serotonin reuptake inhibitors well tolerated in somatizing depressives? Psychopharmacology bulletin, 1994, Volume: 30, Issue:2 Topics: Adult; Aged; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Somatoform Disorders	1994
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology, 1994, Volume: 115, Issue:1-2 Topics: Adolescent; Adult; Aged; Blood Platelets; Cell Membrane; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Lofepramine; Male; Middle Aged; Paroxetine; Receptors, Serotonin	1994
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. Journal of psychiatry & neuroscience : JPN, 1995, Volume: 20, Issue:1 Topics: Adolescent; Adult; Biomarkers; Blood Platelets; Depressive Disorder; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Radioligand Assay; Receptors, Serotonin; Sex Factors; Up-Regulation	1995
The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:6 Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Drug Administration Schedule; Electrocardiography; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Paroxetine	1994
[Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine]. Fortschritte der Neurologie-Psychiatrie, 1994, Volume: 62 Suppl 1 Topics: Aged; Aged, 80 and over; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales	1994
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:4 Topics: Adolescent; Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Treatment Outcome	1994
Childhood psychopathology retrospectively assessed among adults with early onset major depression. Journal of affective disorders, 1994, Volume: 31, Issue:3 Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	1994
Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry, 1994, Volume: 27, Issue:3 Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine	1994
A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients. Acta psychiatrica Scandinavica, 1994, Volume: 89, Issue:6 Topics: Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Hospitalization; Humans; Imipramine; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1994
A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6 Suppl 2 Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; France; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Treatment Outcome	1993
A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6 Suppl 2 Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Paroxetine; Personality Inventory	1993
Long-term treatment of major depressive disorder with paroxetine. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6 Suppl 2 Topics: Adolescent; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Personality Inventory; Recurrence	1993
A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:6 Suppl 2 Topics: Aged; Aged, 80 and over; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Geriatric Assessment; Humans; Male; Mental Status Schedule; Middle Aged; Paroxetine; Personality Inventory; Treatment Outcome	1993
Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. International clinical psychopharmacology, 1994,Spring, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Cognition Disorders; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Geriatric Assessment; Humans; Male; Middle Aged; Neuropsychological Tests; Paroxetine; Personality Inventory; Social Behavior; Treatment Outcome	1994
Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1994, Volume: 4, Issue:1 Topics: Adult; Depressive Disorder; Double-Blind Method; Humans; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Suicide	1994
Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. International clinical psychopharmacology, 1993,Fall, Volume: 8, Issue:3 Topics: Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Time Factors; Treatment Outcome	1993
Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study. Biological psychiatry, 1993, Oct-15, Volume: 34, Issue:8 Topics: Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Homovanillic Acid; Humans; Hydrocortisone; Male; Middle Aged; Paroxetine; Personality Inventory; Pilot Projects; Prolactin; Treatment Outcome	1993
A study comparing paroxetine placebo and imipramine in depressed patients. Journal of affective disorders, 1993, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine; Personality Inventory	1993
Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry, 1993, Volume: 26, Issue:3 Topics: Amitriptyline; Depressive Disorder; Double-Blind Method; Humans; Paroxetine; Psychiatric Status Rating Scales	1993
A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta psychiatrica Scandinavica, 1993, Volume: 87, Issue:2 Topics: Adolescent; Adult; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nausea; Paroxetine; Vomiting	1993
Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine. Biological psychiatry, 1993, Mar-01, Volume: 33, Issue:5 Topics: Adult; Depressive Disorder; Homovanillic Acid; Humans; Male; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Placebos; Selective Serotonin Reuptake Inhibitors	1993
A comparison of paroxetine and placebo in depressed outpatients. Acta psychiatrica Scandinavica, 1993, Volume: 87, Issue:5 Topics: Adolescent; Adult; Aged; Ambulatory Care; Arousal; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index	1993
Mortality in major affective disorder: relationship to subtype of depression. The Danish University Antidepressant Group. Acta psychiatrica Scandinavica, 1993, Volume: 87, Issue:5 Topics: Adult; Aged; Citalopram; Clomipramine; Denmark; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Suicide	1993
Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:7 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Canada; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Depressive Disorder; Direct Service Costs; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine; Patient Readmission; Treatment Outcome	1995
Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:2 Topics: Adult; Aged; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Methylphenidate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1996
Response to an open trial of a second SSRI in major depression. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:3 Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles	1996
A double-blind, multicentre study of paroxetine and maprotiline in major depression. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Paroxetine; Safety	1996
Paroxetine and amitriptyline in the treatment of depression in general practice. Acta psychiatrica Scandinavica, 1996, Volume: 93, Issue:3 Topics: Adolescent; Adult; Aged; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Denmark; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Family Practice; Female; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Treatment Outcome	1996
Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:4 Topics: Adult; Aged; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1996
Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Psychopharmacology bulletin, 1995, Volume: 31, Issue:4 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Nortriptyline; Paroxetine; Posture; Psychiatric Status Rating Scales	1995
High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression. The American journal of psychiatry, 1996, Volume: 153, Issue:11 Topics: Age Factors; Age of Onset; Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium; Male; Nortriptyline; Paroxetine; Perphenazine; Placebos; Psychotherapy; Recurrence; Risk Factors; Treatment Outcome	1996
Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta psychiatrica Scandinavica, 1996, Volume: 94, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Denmark; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Paroxetine; Personality Inventory; Recurrence; Treatment Outcome	1996
Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients. International clinical psychopharmacology, 1996, Volume: 11, Issue:3 Topics: Adult; Benzamides; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Nausea; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders	1996
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. The American journal of psychiatry, 1996, Volume: 153, Issue:12 Topics: 1-Naphthylamine; Delusions; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1996
Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biological psychiatry, 1997, Jan-15, Volume: 41, Issue:2 Topics: Adult; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Personality Inventory; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin	1997
An open-label study of SSRI treatment in depressed hispanic and non-Hispanic women. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:1 Topics: Adult; Depressive Disorder; Female; Fluoxetine; Hispanic or Latino; Humans; Middle Aged; Paroxetine; Prospective Studies; Treatment Outcome	1997
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms. General hospital psychiatry, 1997, Volume: 19, Issue:2 Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders	1997
A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety Disorders; Clomipramine; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Headache; Humans; Middle Aged; Nausea; Paroxetine; Patient Dropouts; Placebos; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Tremor; Xerostomia	1997
Personality disorder scores improve with effective pharmacotherapy of depression. Journal of affective disorders, 1997, Volume: 43, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Ergolines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Disorders; Personality Inventory; Serotonin Antagonists	1997
Economic evaluation of paroxetine and imipramine in depressed outpatients. Psychopharmacology bulletin, 1997, Volume: 33, Issue:1 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Outpatients; Paroxetine; Retrospective Studies; Treatment Outcome	1997
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response. Acta psychiatrica Scandinavica, 1997, Volume: 95, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Maprotiline; Middle Aged; Paroxetine; Personality Inventory; Prospective Studies; Treatment Outcome	1997
A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4 Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Fluvoxamine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Sweating; Treatment Outcome; Xerostomia	1997
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:5 Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome	1997
A double-blind study comparing paroxetine and maprotiline in depressed outpatients. Pharmacopsychiatry, 1997, Volume: 30, Issue:3 Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Paroxetine; Psychiatric Status Rating Scales	1997
Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. International clinical psychopharmacology, 1997, Volume: 12, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Pindolol; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1997
Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. Journal of affective disorders, 1997, Volume: 44, Issue:2-3 Topics: Adrenergic beta-Agonists; Adult; Depressive Disorder; Double-Blind Method; Ego; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Personality; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Temperament; Time Factors	1997
Selective serotonin reuptake inhibitors plus pindolol. Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073 Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Sympatholytics	1997
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis. Journal of affective disorders, 1997, Volume: 45, Issue:3 Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	1997
Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline. Journal of affective disorders, 1997, Volume: 45, Issue:3 Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Paroxetine; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Xerostomia	1997
Antidepressant response follows an exponential decay curve: replication and extension. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:5 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Imipramine; Models, Statistical; Paroxetine; Personality Inventory; Psychometrics; Pyridazines; Treatment Outcome	1997
Paroxetine in children with major depressive disorder: an open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:10 Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder; Female; Humans; Male; Paroxetine	1997
The impact of treatment resistance on depressive relapse following electroconvulsive therapy. Acta psychiatrica Scandinavica, 1997, Volume: 96, Issue:5 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Humans; Imipramine; Paroxetine; Recurrence; Treatment Outcome	1997
How long should pindolol be associated with paroxetine to improve the antidepressant response? Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Male; Metoprolol; Middle Aged; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Time Factors	1997
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA, 1998, Jan-28, Volume: 279, Issue:4 Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Heart Function Tests; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1998
Use of SSRIs in "very old" depressed nursing home residents. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1998,Winter, Volume: 6, Issue:1 Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric	1998
A protocol for the pharmacologic treatment of major depression. A field test of a potential prototype. Journal of affective disorders, 1998, Volume: 47, Issue:1-3 Topics: Adolescent; Adult; Aged; Clinical Protocols; Depressive Disorder; Female; Humans; Lithium; Lofepramine; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Psychiatric Status Rating Scales; Research Design; Treatment Outcome	1998
Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. The American journal of psychiatry, 1998, Volume: 155, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Ambulatory Care; Comorbidity; Depressive Disorder; Female; HIV Infections; Humans; Imipramine; Male; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1998
A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia. International journal of geriatric psychiatry, 1998, Volume: 13, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dementia; Depressive Disorder; Double-Blind Method; Drug Tolerance; Female; Humans; Imipramine; Male; Paroxetine; Prospective Studies; Time Factors; Treatment Outcome	1998
Brain 5-HT neurotransmission during paroxetine treatment. The British journal of psychiatry : the journal of mental science, 1998, Volume: 172 Topics: Adult; Cross-Over Studies; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Single-Blind Method; Synaptic Transmission	1998
The effect of clinical outcome on platelet G proteins of major depressed patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1998, Volume: 8, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Blotting, Western; Clomipramine; Depressive Disorder; Female; GTP-Binding Proteins; Humans; Imipramine; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Signal Transduction; Treatment Outcome	1998
Dose-response efficacy of paroxetine in preventing depressive recurrences: a randomized, double-blind study. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5 Topics: Adult; Age of Onset; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome	1998
A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5 Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; Female; Grief; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome	1998
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological psychiatry, 1998, Jul-15, Volume: 44, Issue:2 Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires	1998
[Characteristics of clinical effects of paxil in the treatment of endogenous depression]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1998, Volume: 98, Issue:6 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Time Factors	1998
Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. The American journal of psychiatry, 1998, Volume: 155, Issue:8 Topics: Aged; Cholinergic Antagonists; Depressive Disorder; Humans; Nortriptyline; Paroxetine; Radioligand Assay; Receptors, Muscarinic; Tachycardia; Xerostomia	1998
One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks. International clinical psychopharmacology, 1998, Volume: 13, Issue:4 Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	1998
Cost effectiveness study of a year follow-up of selective serotonin reuptake inhibitor (SSRI) and augmentor combination compared with SSRI and placebo. International clinical psychopharmacology, 1998, Volume: 13, Issue:4 Topics: Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; United Kingdom	1998
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (New York, N.Y.), 1998, Sep-11, Volume: 281, Issue:5383 Topics: Adolescent; Adult; Aged; Amygdala; Animals; Antidepressive Agents, Second-Generation; Aprepitant; Behavior, Animal; Brain; Depressive Disorder; Female; Gerbillinae; Guinea Pigs; Humans; Male; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Norepinephrine; Paroxetine; Receptors, Neurokinin-1; Serotonin; Stress, Psychological; Substance P; Vocalization, Animal	1998
Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique. The American journal of psychiatry, 1998, Volume: 155, Issue:10 Topics: Adrenergic beta-Antagonists; Adult; Depressive Disorder; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	1998
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biological psychiatry, 1998, Dec-01, Volume: 44, Issue:11 Topics: Adult; Antidepressive Agents; Brain; Brain Stem; Carrier Proteins; Cocaine; Depressive Disorder; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Psychiatric Status Rating Scales; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon	1998
Substance-P antagonists: a new treatment for depression? Lancet (London, England), 1998, Nov-21, Volume: 352, Issue:9141 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Aprepitant; Depressive Disorder; Double-Blind Method; Humans; Morpholines; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance P	1998
Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 20, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Biomarkers; Blood Platelets; Depressive Disorder; Female; Humans; Male; Middle Aged; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic; Tyrosine; Yohimbine	1999
A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12 Topics: Adult; Aged; Buspirone; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Placebo Effect; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome	1998
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1998, Volume: 10, Issue:4 Topics: Adult; Ambulatory Care; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Gastrointestinal Diseases; Humans; Male; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Sexual Dysfunctions, Psychological; Treatment Outcome	1998
Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; Electroencephalography; Female; Humans; Male; Middle Aged; Multivariate Analysis; Paroxetine; Personality Inventory; Pilot Projects; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome	1999
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Archives of general psychiatry, 1999, Volume: 56, Issue:4 Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Pindolol; Placebos; Selective Serotonin Reuptake Inhibitors; Single-Blind Method	1999
Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:2 Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Paroxetine	1999
Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4 Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome	1999
Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. The American journal of psychiatry, 1999, Volume: 156, Issue:5 Topics: Age Factors; Aged; Antidepressive Agents, Second-Generation; Brain; Combined Modality Therapy; Depressive Disorder; Electroencephalography; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Psychiatric Status Rating Scales; Sleep; Sleep Deprivation; Tomography, Emission-Computed; Treatment Outcome	1999
Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. The American journal of psychiatry, 1999, Volume: 156, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice. The Australian and New Zealand journal of psychiatry, 1999, Volume: 33, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Australia; Chi-Square Distribution; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	1999
Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo. Journal of geriatric psychiatry and neurology, 1999,Summer, Volume: 12, Issue:2 Topics: Aged; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Geriatric Psychiatry; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Deprivation	1999
A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Age Factors; Age of Onset; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Age Factors; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Cognitive effects of paroxetine in older depressed patients. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20 Topics: Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Analysis of Variance; Cognition; Cognition Disorders; Depressive Disorder; Hospitalization; Humans; Middle Aged; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Wechsler Scales	1999
Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ (Clinical research ed.), 2000, Jan-01, Volume: 320, Issue:7226 Topics: Adolescent; Adult; Aged; Algorithms; Antidepressive Agents; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder; Fluvoxamine; Humans; Middle Aged; Paroxetine; Problem Solving; Psychotherapy; Treatment Outcome	2000
Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. The British journal of psychiatry : the journal of mental science, 1999, Volume: 175 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride	1999
Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients. Psychopharmacology, 2000, Volume: 147, Issue:4 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Humans; Inpatients; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales	2000
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment. Psychoneuroendocrinology, 2000, Volume: 25, Issue:2 Topics: Adult; Biomarkers; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hemodynamics; Hormones; Humans; Male; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Substance Withdrawal Syndrome	2000
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; beta-Thromboglobulin; Coronary Disease; Depressive Disorder; Double-Blind Method; Humans; Nortriptyline; Paroxetine; Platelet Activation; Platelet Aggregation; Platelet Factor 4	2000
[A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression]. Zentralblatt fur Gynakologie, 2000, Volume: 122, Issue:4 Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Neoplasms; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Personality Inventory; Sick Role	2000
Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:3 Topics: Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Comorbidity; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Risk Factors; Seizures; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2000
The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia. International clinical psychopharmacology, 2000, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride	2000
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. Journal of affective disorders, 2000, Volume: 59, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2000
The serotonin transporter in the midbrain of suicide victims with major depression. Biological psychiatry, 2000, Jun-15, Volume: 47, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Autoradiography; Carrier Proteins; Depressive Disorder; Female; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Middle Aged; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Suicide	2000
Dopaminergic sensitivity and prediction of antidepressant response. Journal of psychopharmacology (Oxford, England), 2000, Volume: 14, Issue:2 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Receptors, Dopamine	2000
Treatment of verbal agitation with a selective serotonin reuptake inhibitor. Journal of geriatric psychiatry and neurology, 2000,Summer, Volume: 13, Issue:2 Topics: Aged; Aged, 80 and over; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Verbal Behavior	2000
Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study. The American journal of psychiatry, 2000, Volume: 157, Issue:9 Topics: Adult; Brain; Brain Chemistry; Depressive Disorder; Double-Blind Method; Female; Fluorine; Fluoxetine; Humans; Magnetic Resonance Spectroscopy; Male; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors	2000
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:5 Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors	2000
Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? Psychiatry research, 2000, Sep-25, Volume: 96, Issue:1 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:5 Topics: Adrenergic alpha-Agonists; Aged; Alleles; Antidepressive Agents, Tricyclic; Carrier Proteins; Depressive Disorder; Double-Blind Method; Female; Genotype; Humans; Lymphocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Norepinephrine; Nortriptyline; Paroxetine; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2000
Mirtazapine compared with paroxetine in major depression. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:9 Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome	2000
Changes in cognitive functioning following treatment of late-life depression. The American journal of psychiatry, 2000, Volume: 157, Issue:12 Topics: Aged; Antidepressive Agents; Cognition Disorders; Comorbidity; Dementia; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome	2000
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:11 Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain	2000
Social support and treatment response in older depressed primary care patients. The journals of gerontology. Series B, Psychological sciences and social sciences, 2001, Volume: 56, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Depressive Disorder; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Primary Health Care; Problem Solving; Social Support; Treatment Outcome	2001
Serotonergic function in major depression and effect of sertraline and paroxetine treatment. International clinical psychopharmacology, 2001, Volume: 16, Issue:2 Topics: Administration, Oral; Adult; Depressive Disorder; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline; Treatment Outcome	2001
Paroxetine for the prevention of depression induced by high-dose interferon alfa. The New England journal of medicine, 2001, Mar-29, Volume: 344, Issue:13 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Depressive Disorder; Disease-Free Survival; Double-Blind Method; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Paroxetine; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors	2001
Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group. The British journal of psychiatry : the journal of mental science, 2001, Volume: 178 Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Diazepam; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Sample Size; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2001
First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression. Neuropsychobiology, 2001, Volume: 43, Issue:3 Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; Delusions; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Inpatients; Male; Middle Aged; Olanzapine; Paroxetine; Patient Discharge; Pirenzepine; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	2001
Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:7 Topics: Adolescent; Analysis of Variance; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Least-Squares Analysis; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Archives of general psychiatry, 2001, Volume: 58, Issue:7 Topics: Adult; Brain; Caudate Nucleus; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Thalamus; Tomography, Emission-Computed; Treatment Outcome	2001
Prolactin response to dl-fenfluramine challenge before and after treatment with paroxetine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 25, Issue:3 Topics: Aged; Biomarkers; Depressive Disorder; Female; Fenfluramine; Humans; Male; Middle Aged; Paroxetine; Prolactin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2001
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2001, Volume: 11, Issue:5 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; DNA; Female; Humans; Individuality; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Tryptophan Hydroxylase	2001
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA, 2001, Dec-19, Volume: 286, Issue:23 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2001
Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. CNS drugs, 2002, Volume: 16, Issue:1 Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Azabicyclo Compounds; Depressive Disorder; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Sleep Wake Disorders; Thiazepines	2002
Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study. International clinical psychopharmacology, 2002, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Sulpiride	2002
Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Anticonvulsants; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazines	2002
A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depression and anxiety, 2002, Volume: 15, Issue:3 Topics: Aged; Aged, 80 and over; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Nursing Homes; Paroxetine; Selective Serotonin Reuptake Inhibitors	2002
Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:5 Topics: Affect; Age Factors; Aged; Ambulatory Care; Anxiety Disorders; Cognition; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome	2002
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. The British journal of psychiatry : the journal of mental science, 2002, Volume: 180 Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep, REM; Triazoles	2002
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. The international journal of neuropsychopharmacology, 2002, Volume: 5, Issue:1 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Genotype; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Pindolol; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sex Characteristics	2002
Facet theoretic analysis of the Hamilton-D scale. Journal of affective disorders, 1992, Volume: 25, Issue:1 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Models, Statistical; Paroxetine; Personality Inventory; Piperidines; Prospective Studies; Psychometrics; Serotonin Antagonists	1992
Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy. Journal of abnormal psychology, 1992, Volume: 101, Issue:3 Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Individuality; Internal-External Control; Interpersonal Relations; Male; Oximes; Paroxetine; Piperidines; Serotonin Antagonists	1992
The effect of paroxetine on anxiety and agitation associated with depression. Psychopharmacology bulletin, 1992, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales	1992
Melancholic/endogenous depression and response to somatic treatment and placebo. The American journal of psychiatry, 1992, Volume: 149, Issue:10 Topics: Antidepressive Agents; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome	1992
A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1992
A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Paroxetine; Psychiatric Status Rating Scales	1992
Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales	1992
A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1992
Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Aged; Aging; Depressive Disorder; Double-Blind Method; Humans; Mianserin; Paroxetine; Psychiatric Status Rating Scales; Sleep	1992
Cardiovascular effects of antidepressants: studies of paroxetine in healthy men and depressed patients. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Blood Pressure; Cardiovascular System; Depressive Disorder; Female; Heart Rate; Humans; Male; Paroxetine	1992
A review of the psychomotor effects of paroxetine. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Adult; Aged; Aging; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychomotor Performance	1992
The anti-anxiety and anti-agitation effects of paroxetine in depressed patients. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Anxiety; Databases, Factual; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Psychomotor Agitation	1992
Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta psychiatrica Scandinavica, 1992, Volume: 86, Issue:6 Topics: Adolescent; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Paroxetine; Personality Inventory	1992
Paroxetine versus placebo: a double-blind comparison in depressed patients. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:12 Topics: Adolescent; Adult; Aged; Ambulatory Care; Arousal; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Paroxetine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index	1992
A double-blind, placebo-controlled study of paroxetine in depressed outpatients. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drugs, Investigational; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Psychiatric Status Rating Scales	1992
The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Psychiatric Status Rating Scales	1992
The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Psychiatric Status Rating Scales	1992
A placebo-controlled trial of paroxetine in the treatment of major depression. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Patient Dropouts; Piperidines; Placebos; Psychiatric Status Rating Scales; Suicide; Time Factors	1992
A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Patient Dropouts; Piperidines; Placebos; Psychiatric Status Rating Scales	1992
Paroxetine in the treatment of depression: a comparison with imipramine and placebo. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adolescent; Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Patient Dropouts; Piperidines; Placebos; Psychiatric Status Rating Scales	1992
A double-blind comparison of paroxetine, imipramine, and placebo in major depression. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Patient Dropouts; Piperidines; Placebos; Prospective Studies; Psychiatric Status Rating Scales	1992
Paroxetine in major depression: a double-blind trial with imipramine and placebo. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Prospective Studies	1992
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. The Journal of clinical psychiatry, 1992, Volume: 53 Suppl Topics: Age Factors; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Paroxetine; Patient Dropouts; Piperidines; Psychiatric Status Rating Scales	1992
Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline. Acta psychiatrica Scandinavica, 1992, Volume: 85, Issue:5 Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin; Serotonin Antagonists	1992
Novel selective serotonin reuptake inhibitors, Part II. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:6 Topics: Adult; Aged; Ambulatory Care; Depressive Disorder; Humans; Imipramine; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Placebos; Recurrence; Serotonin; Serotonin Antagonists	1992
Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta psychiatrica Scandinavica, 1991, Volume: 84, Issue:3 Topics: Amino Acids; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists	1991
A comparison of paroxetine, imipramine and placebo in depressed out-patients. The British journal of psychiatry : the journal of mental science, 1991, Volume: 159 Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine; Personality Tests; Piperidines; Serotonin Antagonists	1991
Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression. Journal of affective disorders, 1990, Volume: 18, Issue:1 Topics: Adult; Aged; Amino Acids; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Serotonin Antagonists; Tryptophan	1990
Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. Journal of affective disorders, 1990, Volume: 18, Issue:4 Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists	1990
A placebo- and imipramine-controlled study of paroxetine. Psychopharmacology bulletin, 1990, Volume: 26, Issue:2 Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Paroxetine; Piperidines; Psychiatric Status Rating Scales	1990
A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Arousal; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Electrocardiography; Electroencephalography; Heart Rate; Humans; Paroxetine; Piperidines; Serotonin Antagonists	1989
Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imipramine; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Evaluation; Female; Hospitals, Psychiatric; Humans; Male; Meta-Analysis as Topic; Middle Aged; Paroxetine; Piperidines; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
A double-blind, multicentre study of paroxetine and mianserin in depression. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Mianserin; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists	1989
A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Adult; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Adult; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Humans; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Piperidines; Randomized Controlled Trials as Topic; Serotonin; Serotonin Antagonists	1989
Paroxetine: pharmacokinetic and antidepressant effect in the elderly. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists	1989
A pharmacokinetic dose titration study in adult and elderly depressed patients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists	1989
The pharmacokinetics of paroxetine in elderly depressed patients. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Piperidines; Serotonin Antagonists	1989
The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo. Psychopharmacology bulletin, 1989, Volume: 25, Issue:2 Topics: Antidepressive Agents; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic	1989
The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo. Psychopharmacology bulletin, 1989, Volume: 25, Issue:2 Topics: Antidepressive Agents; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Paroxetine; Piperidines; Randomized Controlled Trials as Topic	1989
The predictive value of the dexamethasone suppression test. A placebo-controlled study. The British journal of psychiatry : the journal of mental science, 1989, Volume: 155 Topics: Adult; Ambulatory Care; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Female; Humans; Hydrocortisone; Imipramine; Male; Middle Aged; Paroxetine; Piperidines; Placebos; Predictive Value of Tests; Psychiatric Status Rating Scales	1989
Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin. Acta psychiatrica Scandinavica, 1988, Volume: 77, Issue:6 Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Mianserin; Paroxetine; Piperidines; Psychiatric Status Rating Scales	1988
Paroxetine in the treatment of depression--a randomized comparison with amitriptyline. Acta psychiatrica Scandinavica, 1985, Volume: 71, Issue:3 Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Random Allocation; Serotonin Antagonists	1985
Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study). Neuropsychobiology, 1985, Volume: 13, Issue:1-2 Topics: Adolescent; Adult; Amitriptyline; Arrhythmias, Cardiac; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales	1985

Other Studies

327 other study(ies) available for paroxetine and Depressive Disorder

Article	Year
Model-Informed Approach to Assess the Treatment Effect Conditional to the Level of Placebo Response. Clinical pharmacology and therapeutics, 2019, Volume: 106, Issue:6 Topics: Antidepressive Agents; Depressive Disorder; Humans; Models, Statistical; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Treatment Outcome	2019
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series. Postgraduate medicine, 2020, Volume: 132, Issue:2 Topics: Adult; Agoraphobia; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Male; Mental Disorders; Middle Aged; Nordazepam; Panic Disorder; Paroxetine; Psoriasis; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome; Valproic Acid	2020
Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. PloS one, 2017, Volume: 12, Issue:7 Topics: Adult; Antidepressive Agents; Citalopram; Databases, Factual; Depressive Disorder; Drug Monitoring; Female; Fluvoxamine; Humans; Norway; Paroxetine; Pregnancy; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2017
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis. BMJ open, 2017, Aug-03, Volume: 7, Issue:8 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome	2017
Contrasting effects of vortioxetine and paroxetine on pineal gland biochemistry in a tryptophan-depletion model of depression in female rats. Progress in neuro-psychopharmacology & biological psychiatry, 2017, 10-03, Volume: 79, Issue:Pt B Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Depressive Disorder; Disease Models, Animal; Female; Glutamic Acid; Melatonin; Norepinephrine; Paroxetine; Pineal Gland; Piperazines; Random Allocation; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA-Binding Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Tryptophan; Vortioxetine	2017
Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats. Progress in neuro-psychopharmacology & biological psychiatry, 2018, 03-02, Volume: 82 Topics: Administration, Oral; Animals; Biomarkers; Depressive Disorder; Disease Models, Animal; Female; Glutamic Acid; Paroxetine; Random Allocation; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vortioxetine	2018
Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study. Health and quality of life outcomes, 2018, Jan-16, Volume: 16, Issue:1 Topics: Area Under Curve; Depressive Disorder; Female; Humans; Japan; Logistic Models; Male; Paroxetine; Product Surveillance, Postmarketing; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2018
[Discovering potential biomarkers of depression and drug intervention of paroxetine based on (1)H NMR metabolomics]. Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:4 Topics: Antidepressive Agents; Biomarkers; Case-Control Studies; Depressive Disorder; Humans; Magnetic Resonance Imaging; Metabolome; Metabolomics; Paroxetine; Reproducibility of Results; ROC Curve	2016
Prospective Study of the Effectiveness of Paroxetine on the Onset of Posttraumatic Stress Disorder, Depression, and Health and Functional Outcomes After Trauma. Journal of orthopaedic trauma, 2019, Volume: 33, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Quality of Life; Recovery of Function; Stress Disorders, Post-Traumatic; Trauma Centers; Treatment Outcome; Young Adult	2019
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria. Psychiatria Danubina, 2013, Volume: 25, Issue:2 Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2013
New onset alcohol dependence linked to treatment with selective serotonin reuptake inhibitors. The International journal of risk & safety in medicine, 2013, Volume: 25, Issue:2 Topics: Alcoholism; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Substitution; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors	2013
Severe sleepiness and excess sleep duration induced by paroxetine treatment is a beneficial pharmacological effect, not an adverse reaction. Journal of affective disorders, 2013, Sep-25, Volume: 150, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Asian People; Circadian Rhythm; CLOCK Proteins; Cytochrome P-450 CYP2D6; Depressive Disorder; Disorders of Excessive Somnolence; Female; Genotype; Humans; Japan; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Serotonin Plasma Membrane Transport Proteins	2013
[Taperingstrips for paroxetine and venlafaxine]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:10 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Paroxetine; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	2013
Depression-related behavior and mechanical allodynia are blocked by 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene in a mouse model of neuropathic pain induced by partial sciatic nerve ligation. Neuropharmacology, 2014, Volume: 79 Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Male; Mice; Molecular Structure; Neuralgia; Neuropsychological Tests; Organoselenium Compounds; Pain Measurement; Pain Threshold; Paroxetine; Sciatic Neuropathy; Time Factors; Touch	2014
Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans. PLoS medicine, 2014, Volume: 11, Issue:11 Topics: Adult; Amitriptyline; Animals; Antidepressive Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Blood Cells; Depression; Depressive Disorder; Female; Humans; Leukocytes, Mononuclear; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Paroxetine; Rats, Sprague-Dawley; Stress, Psychological; Tacrolimus Binding Proteins; Young Adult	2014
[The interaction of Rhodiola rosea and antidepressants. A case report]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2015, Volume: 29, Issue:1 Topics: Aged; Depressive Disorder; Female; Herb-Drug Interactions; Humans; Paroxetine; Phytotherapy; Plant Extracts; Rhodiola; Self Medication; Serotonin Syndrome; Somatoform Disorders	2015
Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. Neuroscience, 2015, Jan-22, Volume: 284 Topics: Amygdala; Animals; Animals, Newborn; Anxiety Disorders; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Female; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Hippocampus; Male; Maternal Behavior; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors	2015
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects. The international journal of neuropsychopharmacology, 2015, Apr-21, Volume: 18, Issue:10 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antidepressive Agents; Brain; Citalopram; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Female; Histamine; Histidine Decarboxylase; Male; Methylhistidines; Methysergide; Mice, Knockout; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	2015
Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats. Psychopharmacology, 2015, Volume: 232, Issue:19 Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Male; Maze Learning; Mood Disorders; Paroxetine; Rats; Rats, Sprague-Dawley; Sensory Gating; Treatment Outcome	2015
Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors. Psychiatric services (Washington, D.C.), 2015, Dec-01, Volume: 66, Issue:12 Topics: Aged; Aged, 80 and over; Causality; Cohort Studies; Comorbidity; Dementia; Depressive Disorder; Female; Homes for the Aged; Humans; Male; Nursing Homes; Paroxetine; Proportional Hazards Models; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; United States	2015
Breast cancer recurrence in relation to antidepressant use. Cancer causes & control : CCC, 2016, Volume: 27, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Breast Neoplasms; Depressive Disorder; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paroxetine; Risk; Young Adult	2016
The paroxetine controversy: lessons for ketamine trials. The lancet. Psychiatry, 2015, Volume: 2, Issue:12 Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Ketamine; Paroxetine; Selective Serotonin Reuptake Inhibitors	2015
Judge might reopen GSK paroxetine case. BMJ (Clinical research ed.), 2016, Feb-08, Volume: 352 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Industry; England; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2016
Antidepressant-like activity of liposomal formulation containing nimodipine treatment in the tail suspension test, forced swim test and MAOB activity in mice. Brain research, 2016, 09-01, Volume: 1646 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Calcium Channel Blockers; Depressive Disorder; Hindlimb Suspension; Hippocampus; Imipramine; Liposomes; Male; Mice; Monoamine Oxidase; Nimodipine; Paroxetine	2016
Effects of antidepressants on P2X7 receptors. Psychiatry research, 2016, Aug-30, Volume: 242 Topics: Adenosine Triphosphate; Animals; Antidepressive Agents; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Paroxetine; Patch-Clamp Techniques; Platelet Aggregation Inhibitors; Rats; Receptors, Purinergic P2X7	2016
Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:3 Topics: Analysis of Variance; Animals; Antidepressive Agents; Brain; Bupropion; Chromatography, High Pressure Liquid; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Piperidines; Receptors, N-Methyl-D-Aspartate	2017
Toxic epidermal necrolysis after paroxetine treatment. The New Zealand medical journal, 2008, May-23, Volume: 121, Issue:1274 Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Biopsy; Depressive Disorder; Diagnosis, Differential; Family Practice; Female; Humans; Paroxetine; Prednisone; Skin; Stevens-Johnson Syndrome	2008
Observation of treatment of depression in primary care setting in first week - what happens in first week of treatment with antidepressants? Psychiatria Danubina, 2008, Volume: 20, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Diagnosis, Differential; Family Practice; Female; Humans; Male; Middle Aged; Paroxetine; Patient Acceptance of Health Care; Patient Education as Topic; Personality Inventory; Primary Health Care; Slovenia	2008
Benefits of consumer psychoeducation: a pilot program in South Africa. International journal of psychiatry in medicine, 2008, Volume: 38, Issue:1 Topics: Adolescent; Adult; Aged; Attitude of Health Personnel; Attitude to Health; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Drug Utilization; Female; Health Education; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Patient Education as Topic; Physicians, Family; Pilot Projects; Psychiatry; Selective Serotonin Reuptake Inhibitors; South Africa	2008
Recognition and treatment of serotonin syndrome. Canadian family physician Medecin de famille canadien, 2008, Volume: 54, Issue:7 Topics: Aged, 80 and over; Anticonvulsants; Depressive Disorder; Drug Interactions; Humans; Lorazepam; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2008
Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis. Neurochemistry international, 2008, Volume: 53, Issue:6-8 Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Binding, Competitive; Brain; Depressive Disorder; Down-Regulation; Drug Administration Schedule; Drug Interactions; Male; Paroxetine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission	2008
[Paroxetine-induced severe hyponatremic rhabdomyolisis]. Medicina intensiva, 2008, Volume: 32, Issue:7 Topics: Cations; Coma; Depressive Disorder; Diagnosis, Differential; Epilepsy, Tonic-Clonic; Female; Humans; Hyponatremia; Lorazepam; Middle Aged; Muscle Cells; Paroxetine; Rhabdomyolysis; Saline Solution, Hypertonic; Selective Serotonin Reuptake Inhibitors	2008
Unusual weight fluctuation under corticosteroid and psychotropic treatment. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis	2008
Should paroxetine be used to treat depression during pregnancy? The American journal of psychiatry, 2008, Volume: 165, Issue:11 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Secondary Prevention; Substance Withdrawal Syndrome	2008
Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:1 Topics: Age of Onset; Aged; Antidepressive Agents, Second-Generation; Cognition; Depressive Disorder; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Neurophysiology; Neuropsychological Tests; Paroxetine; Prefrontal Cortex; Reaction Time	2009
Early prediction of the effectiveness of antidepressants: inputs from an animal model. Journal of molecular neuroscience : MN, 2009, Volume: 39, Issue:1-2 Topics: Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Desipramine; Dopamine Agents; Female; Humans; Male; Models, Animal; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Treatment Outcome	2009
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. The American journal of psychiatry, 2009, Volume: 166, Issue:5 Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride	2009
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. Psychiatry research, 2009, May-15, Volume: 167, Issue:1-2 Topics: Adult; Antidepressive Agents; Asian People; Depressive Disorder; Depressive Disorder, Major; Female; Fluvoxamine; Gene Frequency; Genetic Variation; Genotype; Humans; Italy; Male; Middle Aged; Paroxetine; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; White People	2009
TORDIA: unique opportunity to explore half-life theory. The American journal of psychiatry, 2009, Volume: 166, Issue:8 Topics: Adolescent; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Half-Life; Humans; Paroxetine; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide; Venlafaxine Hydrochloride	2009
Influence of the media on women taking antidepressants during pregnancy. The Journal of clinical psychiatry, 2009, Volume: 70, Issue:9 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Cardiovascular Abnormalities; Depressive Disorder; Drug Industry; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Internet; Mass Media; Paroxetine; Physician-Patient Relations; Pregnancy; Pregnancy Complications; Prevalence	2009
Challenges in the identification and management of HSDD. The Journal of family practice, 2009, Volume: 58, Issue:7 Suppl Hy Topics: Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Recurrence; Risk Factors; Sexual Dysfunctions, Psychological; Treatment Outcome	2009
GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects. BMJ (Clinical research ed.), 2009, Oct-15, Volume: 339 Topics: Antidepressive Agents, Second-Generation; Child, Preschool; Compensation and Redress; Depressive Disorder; Drug Industry; Female; Heart Defects, Congenital; Humans; Male; Paroxetine; Philadelphia; Pregnancy; Pregnancy Complications	2009
A sleepy patient with REM rebound. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2009, Aug-15, Volume: 5, Issue:4 Topics: Adult; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Humans; Male; Narcolepsy; Paroxetine; Polysomnography; Sleep Wake Disorders; Trazodone	2009
Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in adult male Wistar rats. Journal of neuroscience research, 2010, May-15, Volume: 88, Issue:7 Topics: Animals; Binding, Competitive; Brain; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Depressive Disorder; Disease Models, Animal; Hyperemia; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan; Vasodilation	2010
Agomelatine: new drug. Adverse effects and no proven efficacy. Prescrire international, 2009, Volume: 18, Issue:104 Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride	2009
Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome. Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Administration Schedule; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Substance Withdrawal Syndrome	2010
Dissecting dementia, depression, and drug effects in older adults. Journal of psychosocial nursing and mental health services, 2010, Volume: 48, Issue:1 Topics: Aged; Alzheimer Disease; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Nootropic Agents; Nursing Diagnosis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Substance Withdrawal Syndrome	2010
Interaction of serotonin reuptake inhibitors with tamoxifen. BMJ (Clinical research ed.), 2010, Feb-08, Volume: 340 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Depressive Disorder; Drug Interactions; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2010
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ (Clinical research ed.), 2010, Feb-08, Volume: 340 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cohort Studies; Depressive Disorder; Drug Interactions; Female; Humans; Ontario; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2010
SSRIs and tamoxifen. Why condemn fluoxetine? BMJ (Clinical research ed.), 2010, Mar-10, Volume: 340 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tamoxifen	2010
Syndrome of inappropriate secretion of anti-diuretic hormone in an elderly depressive patient receiving paroxetine: a case report. International journal of geriatric psychiatry, 2010, Volume: 25, Issue:4 Topics: Amoxapine; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sodium; Treatment Outcome	2010
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics, 2010, Volume: 125, Issue:5 Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted	2010
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Archives of general psychiatry, 2010, Volume: 67, Issue:5 Topics: Adult; Aged; Antidepressive Agents; British Columbia; Cause of Death; Citalopram; Cohort Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted	2010
Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Jul-13, Volume: 182, Issue:10 Topics: Abortion, Spontaneous; Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Case-Control Studies; Confidence Intervals; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gestational Age; Humans; Middle Aged; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Quebec; Registries; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult	2010
Research indicates antidepressants may be best for severe depression. Mayo Clinic women's healthsource, 2010, Volume: 14, Issue:7 Topics: Antidepressive Agents; Depressive Disorder; Health Knowledge, Attitudes, Practice; Humans; Paroxetine; Randomized Controlled Trials as Topic; Research Design	2010
Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression. Human psychopharmacology, 2010, Volume: 25, Issue:7-8 Topics: Adult; Depression; Depressive Disorder; Drug Substitution; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome; Young Adult	2010
The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4 Topics: Adult; Aged; Asian People; Biomarkers; Brain-Derived Neurotrophic Factor; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Heterozygote; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2011
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. Pharmacogenomics, 2011, Volume: 12, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Genetic Association Studies; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1B; Severity of Illness Index; Suicidal Ideation; Tacrolimus Binding Proteins; Triazoles; Venlafaxine Hydrochloride; Young Adult	2011
Venlafaxine in somatopsychic and autopsychic depersonalization. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Dec-01, Volume: 35, Issue:8 Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult	2011
Professor files complaint of scientific misconduct over allegation of ghostwriting. BMJ (Clinical research ed.), 2011, Jul-13, Volume: 343 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Industry; Humans; Paroxetine; Pennsylvania; Plagiarism; Publishing; Scientific Misconduct	2011
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study. Psychiatria Danubina, 2011, Volume: 23, Issue:4 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; MMPI; Neurotic Disorders; Observer Variation; Paroxetine; Psychometrics; Reproducibility of Results; Sertraline; Statistics as Topic; Young Adult	2011
Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:7 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Korea; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Outpatients; Paroxetine; Retrospective Studies; Venlafaxine Hydrochloride	2011
High venlafaxine serum levels after prior fluoxetine medication. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:2 Topics: Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2012
A case of serial nightmares and oneiroid state under paroxetine for senile depression. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2012, Volume: 12, Issue:1 Topics: Aged; Antidepressive Agents, Second-Generation; Delusions; Depressive Disorder; Dreams; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Paroxetine; Psychiatric Status Rating Scales	2012
Depressive state due to isolated adrenocorticotropic hormone deficiency underlies school refusal. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:3 Topics: Adolescent; Adrenal Insufficiency; Adrenocorticotropic Hormone; Antidepressive Agents, Second-Generation; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Paroxetine; Schools	2012
Glad about SAD (PD). Neurology, 2012, Apr-17, Volume: 78, Issue:16 Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride	2012
Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response. Translational psychiatry, 2012, Oct-23, Volume: 2 Topics: Activin Receptors, Type I; Activins; Adult; Aged; Amygdala; Animals; Antidepressive Agents; Behavior, Animal; Brain; Dentate Gyrus; Depressive Disorder; Female; Genetic Association Studies; Genotype; Humans; Male; Mice; Middle Aged; Paroxetine; Pharmacogenetics; Polymorphism, Single Nucleotide; Proteoglycans; Receptors, Transforming Growth Factor beta; RNA, Messenger; Signal Transduction	2012
Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice. Brain research bulletin, 2013, Volume: 95 Topics: Animals; Antidepressive Agents; Creatine; Depression; Depressive Disorder; Hindlimb Suspension; Humans; Mice; Paroxetine; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists	2013
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer. Therapeutic drug monitoring, 2002, Volume: 24, Issue:4 Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Clorazepate Dipotassium; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Interactions; Drug Overdose; Female; Half-Life; Humans; Middle Aged; Paroxetine; Suicide, Attempted	2002
Paroxetine for multiple chemical sensitivity syndrome. The American journal of psychiatry, 2002, Volume: 159, Issue:8 Topics: Adult; Comorbidity; Depressive Disorder; Female; Humans; Multiple Chemical Sensitivity; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2002
Risk factors for falls during treatment of late-life depression. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:10 Topics: Accidental Falls; Age Factors; Aged; Antidepressive Agents; Blood Pressure; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Hypotension, Orthostatic; Male; Multivariate Analysis; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Psychotherapy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Survival Analysis	2002
Photosensitivity induced by paroxetine. Contact dermatitis, 2002, Volume: 47, Issue:2 Topics: Allergens; Depressive Disorder; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Patch Tests; Photosensitivity Disorders; Risk Assessment	2002
Selective serotonin reuptake inhibitor. Discontinuation syndrome. Journal of psychosocial nursing and mental health services, 2002, Volume: 40, Issue:12 Topics: Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Dizziness; Drug Administration Schedule; Humans; Male; Nurse Practitioners; Paroxetine; Patient Education as Topic; Psychiatric Nursing; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Refusal	2002
Omega-3 fatty acids for depression in pregnancy. The American journal of psychiatry, 2003, Volume: 160, Issue:2 Topics: Adult; Depressive Disorder; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. The American journal of psychiatry, 2003, Volume: 160, Issue:3 Topics: Adult; Brain; Caudate Nucleus; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Prefrontal Cortex; Probability; Prognosis; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed; Treatment Outcome	2003
Clinical practice guidelines for depression in young people. The Medical journal of Australia, 2003, Mar-17, Volume: 178, Issue:6 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Fluoxetine; Humans; Meta-Analysis as Topic; Paroxetine; Placebos; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2003
New dosage-reduction regime to avoid paroxetine discontinuation syndrome. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:2 Topics: Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2003
Drug safety. Conflict-of-interest allegations derail inquiry into antidepressant's 'dark side'. Science (New York, N.Y.), 2003, Apr-04, Volume: 300, Issue:5616 Topics: Antidepressive Agents, Second-Generation; Conflict of Interest; Depressive Disorder; Drug Industry; Female; Humans; Investments; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Suicide; United Kingdom; Violence	2003
Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization. Administration and policy in mental health, 2002, Volume: 30, Issue:2 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Utilization Review; Fluoxetine; Health Maintenance Organizations; Hospitalization; Humans; Medical Audit; Midwestern United States; Paroxetine; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Paroxetine in major depression. Journal of the American Academy of Child and Adolescent Psychiatry, 2003, Volume: 42, Issue:5 Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Depressive Disorder; Female; Humans; Male; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Paroxetine-induced somnambulism. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4 Topics: Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Somnambulism	2003
Placental passage of antidepressant medications. The American journal of psychiatry, 2003, Volume: 160, Issue:5 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline	2003
Paroxetine must not be given to patients under 18. BMJ (Clinical research ed.), 2003, Jun-14, Volume: 326, Issue:7402 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Contraindications; Depressive Disorder; Humans; Infant; Infant, Newborn; Paroxetine; Suicide Prevention	2003
Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea. Neuropsychobiology, 2003, Volume: 48, Issue:1 Topics: Acetophenones; Adult; Aged; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Indoles; Male; Middle Aged; Nausea; Oximes; Paroxetine; Selective Serotonin Reuptake Inhibitors	2003
Pharmacological heterogeneity limits antidepressant study. BMJ (Clinical research ed.), 2003, Aug-02, Volume: 327, Issue:7409 Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Humans; Mianserin; Paroxetine; Selective Serotonin Reuptake Inhibitors	2003
Case of gynecomastia during paroxetine therapy. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:8 Topics: Adult; Breast; Depressive Disorder; Gynecomastia; Humans; Male; Mammaplasty; Paroxetine; Selective Serotonin Reuptake Inhibitors	2003
Induction of mania in depression by paroxetine. Human psychopharmacology, 2003, Volume: 18, Issue:7 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cohort Studies; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies	2003
Causality and collateral estoppel: process and content of recent SSRI litigation. The journal of the American Academy of Psychiatry and the Law, 2003, Volume: 31, Issue:3 Topics: Causality; Depressive Disorder; Drug Industry; Female; Homicide; Humans; Liability, Legal; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicide; Wyoming	2003
FDA questions antidepressant safety for children. Lancet (London, England), 2003, Nov-08, Volume: 362, Issue:9395 Topics: Adolescent; Advisory Committees; Age Factors; Antidepressive Agents; Child; Contraindications; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; United States; United States Food and Drug Administration	2003
Which SSRI? The Medical letter on drugs and therapeutics, 2003, Nov-24, Volume: 45, Issue:1170 Topics: Adolescent; Anxiety; Child; Depressive Disorder; Drug Interactions; Fluoxetine; Half-Life; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicide Prevention	2003
Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:1 Topics: Adult; Aged; Biomarkers; Cyclopropanes; Depressive Disorder; Female; Homovanillic Acid; Hospitals, University; Humans; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Milnacipran; Paroxetine; Patient Selection; Selective Serotonin Reuptake Inhibitors	2004
Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. European journal of pediatrics, 2004, Volume: 163, Issue:3 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Breast Feeding; Case-Control Studies; Depressive Disorder; Female; Humans; Infant; Male; Paroxetine; Patient Compliance; Prospective Studies; Weight Gain	2004
Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors. Managed care interface, 2003, Volume: 16, Issue:12 Topics: Antidepressive Agents; Anxiety Disorders; Delayed-Action Preparations; Demography; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Insurance Claim Reporting; Male; Managed Care Programs; Massachusetts; Paroxetine; Proportional Hazards Models; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Survival Analysis; Treatment Outcome	2003
Suicidal ideas with paroxetine or venlafaxine. Prescrire international, 2004, Volume: 13, Issue:69 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; United States	2004
Antidepressant medications in children. The New England journal of medicine, 2004, Apr-08, Volume: 350, Issue:15 Topics: Adolescent; Antidepressive Agents, Second-Generation; Causality; Child; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Suicide	2004
Pruritus induced by interruption of paroxetine therapy. The British journal of dermatology, 2004, Volume: 150, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dermatologic Agents; Female; Humans; Middle Aged; Paroxetine; Pruritus; Substance Withdrawal Syndrome	2004
[Gynecomastia-galactorrhea during treatment with mirtazapine]. Presse medicale (Paris, France : 1983), 2004, Apr-10, Volume: 33, Issue:7 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Galactorrhea; Gynecomastia; Humans; Hyperprolactinemia; Male; Mianserin; Mirtazapine; Paroxetine; Risk Factors	2004
A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Reproducibility of Results; Survival Analysis; Time Factors	2004
Depressing misrepresentation? Lancet (London, England), 2004, May-22, Volume: 363, Issue:9422 Topics: Antidepressive Agents, Second-Generation; Child; Clinical Trials as Topic; Depressive Disorder; Drug Industry; Drug Information Services; Ethics, Business; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
Antidepressants and children. Buried data can be hazardous to a company's health. Science (New York, N.Y.), 2004, Jun-11, Volume: 304, Issue:5677 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Drug Industry; Humans; New York; Paroxetine; Publishing; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Suicide	2004
It's an ill pill. Mental health today (Brighton, England), 2004 Topics: Consumer Product Safety; Depressive Disorder; Evidence-Based Medicine; Humans; Paroxetine; Public Opinion; Selective Serotonin Reuptake Inhibitors; United Kingdom	2004
Is GSK guilty of fraud? Lancet (London, England), 2004, Jun-12, Volume: 363, Issue:9425 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Disclosure; Drug Industry; Drug Information Services; Humans; New York; Paroxetine; Scientific Misconduct; Treatment Outcome	2004
GlaxoSmithKline to publish clinical trials after US lawsuit. BMJ (Clinical research ed.), 2004, Jun-26, Volume: 328, Issue:7455 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Clinical Trials as Topic; Contraindications; Depressive Disorder; Drug Industry; Humans; Internet; Paroxetine; Publishing; Treatment Failure	2004
Genetics in pharmacokinetics? The American journal of psychiatry, 2004, Volume: 161, Issue:7 Topics: Antidepressive Agents, Tricyclic; Cytochrome P-450 CYP2D6; Depressive Disorder; Dose-Response Relationship, Drug; Genotype; Humans; Mianserin; Mirtazapine; Paroxetine; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors	2004
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:4 Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Psychopharmacology in the New York Times. MedGenMed : Medscape general medicine, 2004, Jun-23, Volume: 6, Issue:2 Topics: Adolescent; Child; Depressive Disorder; Fluoxetine; Humans; Newspapers as Topic; Paroxetine; Psychopharmacology; Selective Serotonin Reuptake Inhibitors	2004
Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine. Neuropsychobiology, 2004, Volume: 50, Issue:3 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dehydroepiandrosterone Sulfate; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine	2004
[Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline]. MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28 Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Attention; Brain; Depressive Disorder; Humans; Morpholines; Motivation; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors	2004
[Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2004, Volume: 32, Issue:4 Topics: Adolescent; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Clomipramine; Depressive Disorder; Female; Follow-Up Studies; Humans; Length of Stay; Outcome Assessment, Health Care; Paroxetine; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2004
Late bilateral acute angle-closure glaucoma after administration of paroxetine in a patient with plateau iris configuration. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2004, Volume: 39, Issue:7 Topics: Acute Disease; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Ultrasonography	2004
Interview quality and signal detection in clinical trials. The American journal of psychiatry, 2005, Volume: 162, Issue:3 Topics: Antidepressive Agents; Clinical Trials, Phase II as Topic; Depressive Disorder; Humans; Interview, Psychological; Multicenter Studies as Topic; Outcome Assessment, Health Care; Paroxetine; Placebo Effect; Placebos; Psychiatric Status Rating Scales; Quality Control; Signal Detection, Psychological; Videoconferencing	2005
[Hepatotoxicity induced by paroxetine]. Medicina clinica, 2005, Mar-19, Volume: 124, Issue:10 Topics: Adult; Chemical and Drug Induced Liver Injury; Depressive Disorder; Female; Humans; Liver Function Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2005
St John's for depression, worts and all. BMJ (Clinical research ed.), 2005, May-14, Volume: 330, Issue:7500 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Humans; Hypericum; Nonprescription Drugs; Paroxetine; Phytotherapy; Randomized Controlled Trials as Topic	2005
Toxic hepatitis associated with paroxetine. International journal of clinical practice, 2005, Volume: 59, Issue:7 Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Humans; Hypersensitivity, Immediate; Male; Middle Aged; Paroxetine	2005
Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome? Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Diagnosis, Differential; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2005
[The serotonin syndrome]. Psychiatrische Praxis, 2005, Volume: 32, Issue:7 Topics: Aged; Antipsychotic Agents; Citalopram; Depressive Disorder; Dibenzothiepins; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Neurologic Examination; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Syndrome	2005
Differences in total medical costs across the SSRIs for the treatment of depression and anxiety. The American journal of managed care, 2005, Volume: 11, Issue:12 Suppl Topics: Adolescent; Adult; Anxiety Disorders; Benchmarking; Comorbidity; Databases as Topic; Depressive Disorder; Drug Utilization Review; Female; Health Care Costs; Humans; Male; Managed Care Programs; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2005
Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders. The American journal of managed care, 2005, Volume: 11, Issue:12 Suppl Topics: Aged; Anxiety Disorders; Benchmarking; Comorbidity; Databases as Topic; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Managed Care Programs; Medicare; Paroxetine; Patient Compliance; Selective Serotonin Reuptake Inhibitors	2005
[Rexetin in the therapy of depressive states]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:11 Topics: Adult; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome	2005
Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:4 Topics: Adolescent; Canada; Child; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Paroxetine; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States	2006
Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine. Journal of anesthesia, 2006, Volume: 20, Issue:2 Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Electrolytes; Humans; Hyponatremia; Inappropriate ADH Syndrome; Intervertebral Disc Displacement; Male; Pain; Paroxetine; Sodium; Spinal Stenosis; Vasopressins	2006
Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Aug-30, Volume: 30, Issue:6 Topics: Aged; Alprazolam; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Male; Neuroleptic Malignant Syndrome; Paroxetine; Psychiatric Status Rating Scales	2006
Counseling pregnant women treated with paroxetine. Concern about cardiac malformations. Canadian family physician Medecin de famille canadien, 2006, Volume: 52 Topics: Canada; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Paroxetine; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Risk; Selective Serotonin Reuptake Inhibitors	2006
Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behavioural brain research, 2006, Sep-25, Volume: 172, Issue:2 Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Escape Reaction; Male; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Tetrazoles	2006
Prevalence and patterns of antidepressant drug use during pregnancy. European journal of clinical pharmacology, 2006, Volume: 62, Issue:10 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Benzodiazepines; Databases, Factual; Depressive Disorder; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Fluoxetine; Humans; Insurance, Pharmaceutical Services; Netherlands; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Prevalence; Time Factors	2006
[Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine]. Tijdschrift voor psychiatrie, 2006, Volume: 48, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride	2006
Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study. Psychopharmacology, 2006, Volume: 189, Issue:2 Topics: Adult; Brain; Cinanserin; Corpus Striatum; Depressive Disorder; Female; Humans; Iodine Radioisotopes; Male; Mesencephalon; Middle Aged; Paroxetine; Radioligand Assay; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thalamus; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2006
Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia. Acta psychiatrica Scandinavica. Supplementum, 2006, Issue:432 Topics: Adolescent; Adult; Aged; Catchment Area, Health; Citalopram; Cost-Benefit Analysis; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Health Expenditures; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Spain	2006
Comment: paroxetine use during pregnancy: is it safe? The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12 Topics: Depressive Disorder; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications	2006
Hold on tight. Psychiatric services (Washington, D.C.), 2006, Volume: 57, Issue:12 Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Paroxetine; Smoking	2006
Paroxetine-induced bruxism effectively treated with tandospirone. The Journal of neuropsychiatry and clinical neurosciences, 2007,Winter, Volume: 19, Issue:1 Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Bruxism; Depressive Disorder; Humans; Isoindoles; Male; Paroxetine; Piperazines; Pyrimidines; Serotonin Receptor Agonists	2007
[Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol]. Medicina clinica, 2007, Mar-24, Volume: 128, Issue:11 Topics: Aged; Aged, 80 and over; Algorithms; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Iatrogenic Disease; Osteoarthritis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Time Factors; Tramadol	2007
Are psychotropics drugs used in pregnancy? Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:9 Topics: Adolescent; Adult; Antidepressive Agents; Benzodiazepines; Cesarean Section; Depressive Disorder; Drug Utilization Review; Feeding and Eating Disorders; Female; Humans; Infant, Newborn; Lithium Compounds; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Psychotropic Drugs; Spain; Surveys and Questionnaires; Treatment Outcome; Withholding Treatment	2007
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:9 Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride	2007
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST). European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:4 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Motor Activity; Paroxetine; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Swimming	2008
Is bigger better for depression trials? Journal of psychiatric research, 2008, Volume: 42, Issue:8 Topics: Adult; Clinical Trials, Phase III as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Patient Selection; Placebos; Randomized Controlled Trials as Topic; Sample Size; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	2008
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British journal of clinical pharmacology, 2008, Volume: 65, Issue:4 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Depressive Disorder; Female; Fetal Development; Humans; Male; Middle Aged; Netherlands; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Risk Assessment; Selective Serotonin Reuptake Inhibitors	2008
Serotonin transporter polymorphism and bleeding time during SSRI therapy. British journal of clinical pharmacology, 2008, Volume: 65, Issue:5 Topics: Adolescent; Adult; Aged; Bleeding Time; Blood Platelets; Depressive Disorder; Female; Genotype; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2008
Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model. Journal of psychiatric research, 2008, Volume: 42, Issue:14 Topics: Antidepressive Agents; Bayes Theorem; Depressive Disorder; Endpoint Determination; Humans; Kaplan-Meier Estimate; Linear Models; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Time Factors; Treatment Outcome	2008
An early clinical phase II evaluation of paroxetine, a new potent and selective 5HT-uptake inhibitor in patients with depressive illness. Pharmacopsychiatria, 1982, Volume: 15, Issue:6 Topics: Adult; Aged; Depressive Disorder; Drug Evaluation; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Serotonin	1982
[Is there a new trend in antidepressive therapy? Bonn, 2 July 1993]. Der Nervenarzt, 1993, Volume: 64, Issue:10 Suppl Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Paroxetine	1993
Effect of paroxetine on seizure length during electroconvulsive therapy. Acta psychiatrica Scandinavica, 1995, Volume: 92, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1995
The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1994, Volume: 4, Issue:1 Topics: Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	1994
Paroxetine in the treatment of inpatients with non-delusional endogenous or neurotic depression. Schweizer Archiv fur Neurologie und Psychiatrie (Zurich, Switzerland : 1985), 1994, Volume: 145, Issue:6 Topics: Adult; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Patient Admission; Personality Inventory; Risk Factors; Suicide; Suicide Prevention	1994
Economics of treatment of depression. The British journal of psychiatry : the journal of mental science, 1995, Volume: 167, Issue:1 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depressive Disorder; Humans; Imipramine; Paroxetine	1995
[Paroxetine in the treatment of depressive disorders (pilot study)]. Ceskoslovenska psychiatrie, 1995, Volume: 91, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine	1995
Paroxetine treatment of anger associated with depression. The Journal of nervous and mental disease, 1995, Volume: 183, Issue:10 Topics: Adult; Anger; Depressive Disorder; Hostility; Humans; Irritable Mood; Male; Paroxetine; Treatment Outcome	1995
Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features. Life sciences, 1995, Volume: 57, Issue:2 Topics: Adult; Anxiety; Blood Platelets; Combat Disorders; Depressive Disorder; Humans; Male; Middle Aged; Paroxetine; Serotonin; Tritium	1995
Paroxetine as migraine prophylaxis. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:7 Topics: Comorbidity; Depressive Disorder; Female; Humans; Middle Aged; Migraine Disorders; Paroxetine; Treatment Outcome	1995
The treatment of refractory depression using paroxetine with lithium augmentation. Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:3 Topics: Aged; Depressive Disorder; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Carbonate; Paroxetine; Treatment Outcome	1995
Editorial statement. Acta psychiatrica Scandinavica, 1995, Volume: 91, Issue:3 Topics: Depressive Disorder; Duplicate Publications as Topic; Humans; Paroxetine; Placebos	1995
Physical symptoms associated with paroxetine withdrawal. The American journal of psychiatry, 1995, Volume: 152, Issue:8 Topics: Adult; Depressive Disorder; Dizziness; Ejaculation; Fatigue; Humans; Male; Middle Aged; Nausea; Paroxetine; Substance Withdrawal Syndrome; Tremor	1995
Adverse interaction of paroxetine and cyproheptadine. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:9 Topics: Cyproheptadine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Paroxetine; Psychoses, Substance-Induced	1995
Paroxetine and akathisia. Biological psychiatry, 1995, Mar-01, Volume: 37, Issue:5 Topics: Akathisia, Drug-Induced; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Neurologic Examination; Paroxetine; Propranolol	1995
Neurochemistry and paroxetine response in major depression. Biological psychiatry, 1995, Mar-15, Volume: 37, Issue:6 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Personality Inventory; Serotonin	1995
Platelet serotonin markers and depressive symptomatology. Biological psychiatry, 1995, Apr-01, Volume: 37, Issue:7 Topics: Adolescent; Adult; Aged; Arousal; Blood Platelets; Brain; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Radioligand Assay; Receptors, Serotonin; Serotonin	1995
Economics of treatment of depression. The British journal of psychiatry : the journal of mental science, 1995, Volume: 166, Issue:3 Topics: Bias; Cost-Benefit Analysis; Depressive Disorder; Humans; Imipramine; Paroxetine; Patient Dropouts	1995
Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification. Journal of affective disorders, 1994, Volume: 32, Issue:1 Topics: Adult; Blood Platelets; Carrier Proteins; Depressive Disorder; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Personality Inventory; Reference Values; Seasons; Serotonin; Serotonin Plasma Membrane Transport Proteins; Suicide	1994
Paroxetine withdrawal syndrome. The American journal of psychiatry, 1995, Volume: 152, Issue:1 Topics: Adult; Anorexia; Anxiety Disorders; Depressive Disorder; Diarrhea; Dizziness; Female; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome	1995
Spontaneous seizure after concurrent use of methohexital anesthesia for electroconvulsive therapy and paroxetine: a case report. The Journal of nervous and mental disease, 1995, Volume: 183, Issue:2 Topics: Adult; Anesthesia; Depressive Disorder; Drug Interactions; Electroconvulsive Therapy; Epilepsy, Tonic-Clonic; Female; Humans; Methohexital; Paroxetine; Seizures	1995
Paroxetine-molindone interaction. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:2 Topics: Aged; Basal Ganglia Diseases; Delusions; Depressive Disorder; Drug Interactions; Female; Humans; Molindone; Parkinson Disease, Secondary; Paroxetine	1995
Cost-effectiveness of antidepressants. The British journal of psychiatry : the journal of mental science, 1994, Volume: 165, Issue:3 Topics: Ambulatory Care; Cost-Benefit Analysis; Depressive Disorder; Humans; Imipramine; Paroxetine; Patient Dropouts; Recurrence	1994
Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine. Psychopharmacology, 1993, Volume: 110, Issue:1-2 Topics: Adult; Biomarkers; Blood Platelets; Cell Membrane; Citalopram; Depressive Disorder; Desipramine; Female; Humans; Imipramine; In Vitro Techniques; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Sodium	1993
Depression and marijuana. The Australian and New Zealand journal of psychiatry, 1994, Volume: 28, Issue:3 Topics: Adult; Bipolar Disorder; Depressive Disorder; Humans; Male; Marijuana Smoking; Paroxetine	1994
Case study: ECT treatment of a young girl with catatonia. Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:3 Topics: Catatonia; Child; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Paroxetine	1995
What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:5 Topics: Antidepressive Agents; Cost of Illness; Cost-Benefit Analysis; Depressive Disorder; Humans; Imipramine; Models, Economic; Paroxetine; Randomized Controlled Trials as Topic; Treatment Outcome; United Kingdom	1994
Further studies on platelet serotonin transporter binding in depression. The American journal of psychiatry, 1994, Volume: 151, Issue:11 Topics: Antidepressive Agents; Blood Proteins; Carrier Proteins; Depressive Disorder; Female; Glycoproteins; Humans; Imipramine; Ligands; Male; Middle Aged; Paroxetine; Radioligand Assay; Receptors, Drug; Serotonin; Serotonin Plasma Membrane Transport Proteins	1994
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents. The Journal of pediatrics, 1994, Volume: 125, Issue:5 Pt 1 Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Drug Interactions; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Recurrence; Sertraline; Substance-Related Disorders; Syndrome	1994
Platelet paroxetine binding in depressed and nondepressed chronic pain patients. Acta psychiatrica Scandinavica, 1994, Volume: 90, Issue:2 Topics: Adult; Aged; Biomarkers; Chronic Disease; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Paroxetine; Receptors, Serotonin	1994
Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age. Psychiatry research, 1994, Volume: 51, Issue:2 Topics: Adult; Age Factors; Binding Sites; Blood Platelets; Depressive Disorder; Desipramine; Female; Fluoxetine; Humans; Imipramine; Infant; Male; Paroxetine; Serotonin	1994
Platelet serotonin measures in primary dysthymia. The American journal of psychiatry, 1994, Volume: 151, Issue:9 Topics: Adult; Blood Platelets; Depressive Disorder; Female; Humans; Male; Middle Aged; Models, Neurological; Paroxetine; Receptors, Serotonin; Serotonin	1994
Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of general psychiatry, 1994, Volume: 51, Issue:3 Topics: Adult; Aged; Animals; Depressive Disorder; Drug Synergism; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Paroxetine; Pilot Projects; Pindolol; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors	1994
Bleeding attributed to the intake of paroxetine. The American journal of psychiatry, 1994, Volume: 151, Issue:5 Topics: Adult; Blood Platelets; Depressive Disorder; Ecchymosis; Female; Humans; Middle Aged; Paroxetine	1994
[Drug of the month. Paroxetine (Seroxar, Aropax)]. Revue medicale de Liege, 1994, Volume: 49, Issue:4 Topics: Affect; Depressive Disorder; Humans; Paroxetine	1994
Safety and efficacy of paroxetine in elderly patients. Geriatrics, 1993, Volume: 48 Suppl 2 Topics: Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Multicenter Studies as Topic; Paroxetine; Safety	1993
Physical symptoms associated with paroxetine discontinuation. The American journal of psychiatry, 1994, Volume: 151, Issue:2 Topics: Adult; Depressive Disorder; Female; Humans; Influenza, Human; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Substance Withdrawal Syndrome	1994
Further evidence for the existence of endogenous serotonin uptake inhibitors and their purification by calmodulin affinity chromatography. Psychiatry research, 1993, Volume: 47, Issue:2 Topics: Adult; Antibodies; Biological Factors; Brain; Calmodulin; Chromatography, Agarose; Chromatography, Gel; Depressive Disorder; Female; Humans; Imipramine; Male; Paroxetine; Radioimmunoassay; Selective Serotonin Reuptake Inhibitors; Serotonin; Structure-Activity Relationship	1993
5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain research, 1993, Jun-18, Volume: 614, Issue:1-2 Topics: Adult; Aged; Amygdala; Binding, Competitive; Cerebral Cortex; Depressive Disorder; Female; Humans; In Vitro Techniques; Ketanserin; Male; Middle Aged; Nerve Tissue Proteins; Paroxetine; Protein Binding; Receptors, Serotonin; Suicide	1993
Paroxetine for treatment of depression. The Medical letter on drugs and therapeutics, 1993, Mar-19, Volume: 35, Issue:892 Topics: Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Humans; Paroxetine	1993
Recurrent hyponatremia associated with fluoxetine and paroxetine. The American journal of psychiatry, 1996, Volume: 153, Issue:1 Topics: Aged; Depressive Disorder; Female; Fluoxetine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Paroxetine; Recurrence	1996
Paroxetine level in breast milk. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:1 Topics: Adult; Breast Feeding; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Humans; Infant, Newborn; Milk, Human; Paroxetine; Puerperal Disorders	1996
Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder. Psychiatry research, 1995, Sep-29, Volume: 58, Issue:2 Topics: Adult; Blood Platelets; Carrier Proteins; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Receptors, Drug; Selective Serotonin Reuptake Inhibitors; Serotonin	1995
Exacerbation of extrapyramidal symptoms with paroxetine. The Australian and New Zealand journal of psychiatry, 1995, Volume: 29, Issue:3 Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Paroxetine	1995
Drug-drug interactions. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:5 Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline	1996
[Adverse effects: priapism caused by paroxetine]. Annales medico-psychologiques, 1996, Volume: 154, Issue:2 Topics: Adult; Antidepressive Agents; Cyproheptadine; Depressive Disorder; Humans; Imipramine; Male; Paroxetine; Priapism; Serotonin Antagonists	1996
Paroxetine and tardive dyskinesia. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3 Topics: Aged; Aged, 80 and over; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1996
Withdrawal syndromes after paroxetine and sertraline discontinuation. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5 Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1995
Paroxetine/bupropion combination treatment for refractory depression. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:1 Topics: Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Middle Aged; Paroxetine	1996
Sertraline and galactorrhea. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:4 Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Galactorrhea; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1996
More cases of paroxetine withdrawal syndrome. The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:3 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1996
Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biological psychiatry, 1996, Oct-01, Volume: 40, Issue:7 Topics: Animals; Blood Platelets; Brain; Carrier Proteins; Depressive Disorder; Dexamethasone; Disease Models, Animal; Gene Expression; Glucocorticoids; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins	1996
Lhermitte's sign in paroxetine withdrawal. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: Adult; Central Nervous System Diseases; Depressive Disorder; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1996
Withdrawal after discontinuation of paroxetine. The Australian and New Zealand journal of psychiatry, 1996, Volume: 30, Issue:5 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Middle Aged; Neurologic Examination; Paroxetine; Substance Withdrawal Syndrome	1996
Effect of valine on 5-HT neurotransmission and mood. Advances in experimental medicine and biology, 1996, Volume: 398 Topics: 1-Naphthylamine; Adult; Affect; Amino Acids, Branched-Chain; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Humans; Lithium; Male; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Valine	1996
Paroxetine-induced angioedema and tongue swelling. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10 Topics: Angioedema; Depressive Disorder; Edema; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tongue Diseases	1996
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. International clinical psychopharmacology, 1996, Volume: 11, Issue:3 Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method	1996
Paroxetine shifts imipramine metabolism. Psychiatry research, 1996, Jan-31, Volume: 59, Issue:3 Topics: Adult; Antidepressive Agents, Tricyclic; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Drug Synergism; Humans; Imipramine; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1996
Reversible hepatotoxicity of paroxetine in a patient with major depression. Pharmacopsychiatry, 1996, Volume: 29, Issue:6 Topics: Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Depressive Disorder; Female; Humans; Liver; Middle Aged; Paroxetine	1996
[Bradycardia after beginning therapy with metoprolol and paroxetine]. Psychiatrische Praxis, 1996, Volume: 23, Issue:5 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Blood Pressure; Bradycardia; Cardiomyopathy, Hypertrophic; Depressive Disorder; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Lithium Carbonate; Metoprolol; Middle Aged; Paroxetine	1996
Withdrawal hypomania associated with paroxetine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Panic Disorder; Paroxetine; Substance Withdrawal Syndrome	1997
Sexual dysfunction associated with serotonin specific reuptake inhibitors. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome	1997
[Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis]. Der Nervenarzt, 1996, Volume: 67, Issue:5 Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzamides; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Trimipramine	1996
Fluoxetine-induced akathisia does not reappear after switch to paroxetine. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:12 Topics: Akathisia, Drug-Induced; Depressive Disorder; Female; Fluoxetine; Hospitalization; Humans; Middle Aged; Paroxetine; Treatment Outcome	1996
The treatment of depression with paroxetine in psychiatric practice in Germany: the possibilities and current limitations of drug monitoring. Pharmacopsychiatry, 1997, Volume: 30, Issue:1 Suppl Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Germany; Humans; Middle Aged; Paroxetine; Private Practice; Product Surveillance, Postmarketing; Psychiatric Status Rating Scales; Psychiatry; Socioeconomic Factors; Time Factors	1997
Paroxetine prevents migraines. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:1 Topics: Adult; Depressive Disorder; Female; Humans; Male; Migraine Disorders; Paroxetine	1997
SSRI optimal dose remains at issue. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2 Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1997
Mania associated with serotonin selective reuptake inhibitors. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2 Topics: Bipolar Disorder; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
Acute angle-closure glaucoma and paroxetine. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:3 Topics: Acute Disease; Aged; Depressive Disorder; Female; Glaucoma, Angle-Closure; Humans; Paroxetine	1997
[The concept of therapeutic use of Paroxetin proves to be successful in clinical practice]. Der Nervenarzt, 1995, Volume: 66, Issue:3 Suppl Topics: Aged; Antidepressive Agents; Depression; Depressive Disorder; Geriatric Psychiatry; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1995
Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine. Depression, 1996, Volume: 4, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Arousal; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Paroxetine; Pindolol; Recurrence; Sympatholytics	1996
Transient, paroxysmal, shock-like paresthesias associated with paroxetine initiation. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4 Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Electric Injuries; Female; Humans; Paresthesia; Paroxetine	1997
Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls. Journal of psychiatry & neuroscience : JPN, 1997, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; Cause of Death; Depressive Disorder; Drug Overdose; Female; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention	1997
Paroxetine-induced anorexia in a patient with bulimia nervosa. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:5 Topics: Adult; Anorexia; Bulimia; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients. Journal of affective disorders, 1997, Volume: 44, Issue:1 Topics: Adult; Age Factors; Aged; Antidepressive Agents; Binding Sites; Blood Platelets; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine	1997
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. International journal of geriatric psychiatry, 1997, Volume: 12, Issue:5 Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Paroxetine in depressed adolescents with intellectual disability: an open label study. Journal of intellectual disability research : JIDR, 1997, Volume: 41 ( Pt 3) Topics: Adolescent; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Intellectual Disability; Male; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome	1997
Selective serotonin reuptake inhibitors plus pindolol. The REEP. Lancet (London, England), 1997, Jul-26, Volume: 350, Issue:9073 Topics: Depressive Disorder; Fluoxetine; Humans; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Sympatholytics	1997
Paroxetine and galactorrhea. Pharmacopsychiatry, 1997, Volume: 30, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Galactorrhea; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
Interaction of serotonin re-uptake inhibitors with perhexiline. The Australian and New Zealand journal of psychiatry, 1997, Volume: 31, Issue:4 Topics: Aged; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Metabolic Clearance Rate; Paroxetine; Perhexiline; Selective Serotonin Reuptake Inhibitors; Vasodilator Agents	1997
[Paroxetine-induced neuroleptic malignant syndrome]. Der Nervenarzt, 1997, Volume: 68, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Hematoma, Subdural; Humans; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Postoperative Complications; Schizophrenia; Schizophrenic Psychology; Suicide, Attempted	1997
Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen? Journal of affective disorders, 1997, Volume: 46, Issue:1 Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Paroxetine; Psychotropic Drugs; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline	1997
Pindolol-paroxetine combination. The American journal of psychiatry, 1997, Volume: 154, Issue:12 Topics: Adult; Age Factors; Animals; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Paroxetine; Pindolol; Placebos; Randomized Controlled Trials as Topic; Rats; Severity of Illness Index; Treatment Outcome	1997
Serotonin syndrome: case report and review of the literature. Connecticut medicine, 1997, Volume: 61, Issue:11 Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome	1997
Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer. Pharmacopsychiatry, 1997, Volume: 30, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Blood Pressure; Central Nervous System Diseases; Clozapine; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dysthymic Disorder; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
Paxil (paroxetine) lifts depression, lowers associated anxiety symptoms. Advance for nurse practitioners, 1997, Volume: 5, Issue:10 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1 Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists	1998
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. Journal of affective disorders, 1998, Volume: 47, Issue:1-3 Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Direct Service Costs; Drug Costs; Fee-for-Service Plans; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Models, Econometric; Multivariate Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	1998
Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients. Journal of affective disorders, 1997, Volume: 46, Issue:2 Topics: Adult; Binding, Competitive; Blood Platelets; Blood Proteins; Cell Membrane; Depressive Disorder; Female; Humans; Imipramine; Immunodiffusion; Male; Middle Aged; Orosomucoid; Paroxetine; Platelet Membrane Glycoproteins; Radioligand Assay; Receptors, Serotonin; Tritium	1997
Breast enlargement during chronic antidepressant therapy. Journal of affective disorders, 1997, Volume: 46, Issue:2 Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain	1997
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacology bulletin, 1997, Volume: 33, Issue:4 Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior	1997
Hyponatremia associated with paroxetine. Pharmacopsychiatry, 1998, Volume: 31, Issue:1 Topics: Aged; Depressive Disorder; Female; Humans; Hyponatremia; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sodium; Vasopressins	1998
Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. The Australian and New Zealand journal of psychiatry, 1998, Volume: 32, Issue:2 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Dementia; Depressive Disorder; Drug Monitoring; Female; Fluoxetine; Humans; Hyponatremia; Male; Middle Aged; Paroxetine; Patient Admission; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sodium	1998
The SSRI antidepressants: exploring their "other" possible properties. Journal of affective disorders, 1998, Volume: 49, Issue:2 Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires	1998
Paroxetine treatment of trichotillomania in an adolescent. Journal of child and adolescent psychopharmacology, 1998, Volume: 8, Issue:1 Topics: Adolescent; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Trichotillomania	1998
Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline. Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:7 Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Blood Platelets; Carrier Proteins; Child; Depressive Disorder; Female; Humans; Kinetics; Male; Paroxetine; Serotonin; Sertraline	1998
The serotonin syndrome scale: first results on validity. European archives of psychiatry and clinical neuroscience, 1998, Volume: 248, Issue:2 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Syndrome	1998
Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome. Biological psychiatry, 1998, Aug-15, Volume: 44, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Benzamides; Biomarkers; Biopterins; Blood Platelets; Depressive Disorder; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Treatment Outcome; Viloxazine	1998
[ECG changes after paroxetine. 3 case reports]. Der Nervenarzt, 1998, Volume: 69, Issue:7 Topics: Aged; Antidepressive Agents, Second-Generation; Arrhythmias, Cardiac; Bradycardia; Depressive Disorder; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Paroxetine	1998
Sexual dysfunction and selective serotonin reuptake inhibitors. Biological psychiatry, 1998, Sep-01, Volume: 44, Issue:5 Topics: Adult; Depressive Disorder; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological	1998
Successful paroxetine treatment of major depression in an adult form of metachromatic leukodystrophy with cognitive disturbances. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Cognition Disorders; Depressive Disorder; Female; Humans; Leukodystrophy, Metachromatic; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1998
Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat. Journal of neuroscience research, 1998, Oct-01, Volume: 54, Issue:1 Topics: Animals; Apoenzymes; Binding Sites; Brain Chemistry; Carrier Proteins; Cerebral Cortex; Chromatography, High Pressure Liquid; Depressive Disorder; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hydroxyindoleacetic Acid; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Olfactory Bulb; Paroxetine; Rats; Rats, Wistar; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synapses; Tryptophan Hydroxylase	1998
Discontinuation symptoms and SSRIs. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Biological Availability; Depressive Disorder; Dizziness; Fluoxetine; Follow-Up Studies; Half-Life; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998
Discontinuation of antidepressant therapy: emerging complications and their relevance. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Syndrome; Terminology as Topic	1998
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent. Archives of general psychiatry, 1998, Volume: 55, Issue:11 Topics: Adolescent; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Paroxetine; Piperazines; Tacrolimus; Triazoles	1998
Tricyclic antidepressants in adolescent depression. A case report. European child & adolescent psychiatry, 1998, Volume: 7, Issue:3 Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Depressive Disorder; Dothiepin; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Humans; Lithium Carbonate; Lofepramine; Male; Paroxetine; Trazodone	1998
Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Adenylyl Cyclases; Aging; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Behavior, Animal; Body Weight; Brain; Carrier Proteins; Depressive Disorder; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Reflex, Startle; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins	1999
Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities. Journal of clinical psychology, 1999, Volume: 55, Issue:1 Topics: Depressive Disorder; Drug Costs; Drug Prescriptions; Fluoxetine; Hospitals, Veterans; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1999
Cost analysis of paroxetine versus imipramine in major depression. PharmacoEconomics, 1995, Volume: 8, Issue:3 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Computer Simulation; Costs and Cost Analysis; Depressive Disorder; Humans; Imipramine; Insurance, Health, Reimbursement; Models, Economic; Paroxetine; Patient Dropouts; Recurrence; Treatment Failure; United States	1995
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis. Medical care, 1999, Volume: 37, Issue:4 Suppl Li Topics: Adult; Databases, Factual; Depressive Disorder; Drug Utilization; Episode of Care; Female; Fluoxetine; Humans; Logistic Models; Male; Multivariate Analysis; Paroxetine; Psychotherapy; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	1999
Selective serotonin reuptake inhibitors and delusional depression. The American journal of psychiatry, 1999, Volume: 156, Issue:6 Topics: Comorbidity; Delusions; Depressive Disorder; Humans; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1999
Alteration of personality by serotonergic intervention. The American journal of psychiatry, 1999, Volume: 156, Issue:6 Topics: Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality; Personality Assessment; Placebos; Psychometrics; Research Design; Selective Serotonin Reuptake Inhibitors	1999
Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine--a case report. Psychopharmacology, 1999, Volume: 143, Issue:4 Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Paroxetine	1999
[Severe withdrawal symptoms with fever during paroxetine tapering off]. Nederlands tijdschrift voor geneeskunde, 1999, Jul-03, Volume: 143, Issue:27 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Fever; Humans; Male; Paroxetine; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1999
Safety of antidepressant use in pregnant and nursing women. JAMA, 1999, Jul-21, Volume: 282, Issue:3 Topics: Antidepressive Agents; Breast Feeding; Depression, Postpartum; Depressive Disorder; Female; Humans; Infant, Newborn; Lactation; Paroxetine; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Selective Serotonin Reuptake Inhibitors; Sleep	1999
[Proofs of efficacy]. L'Encephale, 1999, Volume: 25 Spec No 2 Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
Paroxetine pharmacokinetics in depressed children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:8 Topics: Adolescent; Biotransformation; Catechol O-Methyltransferase; Child; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Humans; Male; Paroxetine; Phenotype; Selective Serotonin Reuptake Inhibitors	1999
Excretion of paroxetine into breast milk. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8 Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides	1999
Economic appraisal of citalopram in the management of single-episode depression. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:5 Suppl 1 Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Health Maintenance Organizations; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Retrospective Studies; Sertraline	1999
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline. The American journal of managed care, 1999, Volume: 5, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cost of Illness; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Care Costs; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	1999
Treatment of kleptomania with paroxetine. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:11 Topics: Adult; Comorbidity; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	1999
Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clinical pharmacology and therapeutics, 1999, Volume: 66, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Case-Control Studies; Clomipramine; Depressive Disorder; Female; Fluoxetine; Humans; Inositol 1,4,5-Trisphosphate; Male; Middle Aged; Paroxetine; Platelet Aggregation; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Time Factors	1999
Paroxetine in human breast milk and nursing infants. The American journal of psychiatry, 2000, Volume: 157, Issue:2 Topics: Breast Feeding; Chromatography, High Pressure Liquid; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant, Newborn; Milk, Human; Paroxetine; Pregnancy; Puerperal Disorders	2000
Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 22, Issue:4 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Free Radical Scavengers; Hippocampus; Imipramine; Lithium; Male; Monoamine Oxidase Inhibitors; Paroxetine; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Tranylcypromine	2000
Lack of desipramine toxicity with citalopram. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Depressive Disorder; Desipramine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liver; Middle Aged; Paroxetine	2000
Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacology, biochemistry, and behavior, 2000, Volume: 65, Issue:4 Topics: Amygdala; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Biogenic Amines; Brain Chemistry; Cerebral Cortex; Corticosterone; Cyclohexanols; Depressive Disorder; Desipramine; Hormones; Hypothalamo-Hypophyseal System; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Venlafaxine Hydrochloride	2000
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants. Neurogastroenterology and motility, 2000, Volume: 12, Issue:2 Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; Clomipramine; Colon; Colonoscopy; Constipation; Depressive Disorder; Eating; Fecal Impaction; Female; Gastrointestinal Motility; Humans; Male; Manometry; Maprotiline; Middle Aged; Mood Disorders; Muscle Contraction; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiazepines; Viloxazine	2000
Drug therapy in treatment-resistant depression. The British journal of psychiatry : the journal of mental science, 1999, Volume: 175 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride	1999
[Withdrawal syndrome after the use of serotonin reuptake inhibitors]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000, Mar-20, Volume: 120, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2000
Newer antidepressants: a comparison of tolerability in general practice. The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:448 Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride	1999
Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Biological psychiatry, 2000, May-01, Volume: 47, Issue:9 Topics: Antidepressive Agents, Second-Generation; Blood Platelets; Depressive Disorder; Humans; Paroxetine; Predictive Value of Tests; Serotonin	2000
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4 Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride	2000
Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:5 Topics: Adult; Analysis of Variance; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Analysis, Statistical; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Personality; Personality Disorders; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2000
[Alopecia due to Seroxat therapy]. Harefuah, 2000, Apr-02, Volume: 138, Issue:7 Topics: Alopecia; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine	2000
Paroxetine and irritable bowel syndrome. The American journal of psychiatry, 2000, Volume: 157, Issue:9 Topics: Adult; Colonic Diseases, Functional; Comorbidity; Depressive Disorder; Drug Administration Schedule; Humans; Male; Paroxetine; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome	2000
Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Archives of general psychiatry, 2000, Volume: 57, Issue:9 Topics: Adenosine Triphosphate; beta-Thromboglobulin; Blood Platelets; Depressive Disorder; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Paroxetine; Peptide Fragments; Physical Exertion; Platelet Activation; Platelet Aggregation; Platelet Count; Platelet Factor 4; Receptors, Thrombin; Regression Analysis; Risk Factors; Selective Serotonin Reuptake Inhibitors	2000
Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5 Topics: Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Humans; Male; Paroxetine; Substance Withdrawal Syndrome	2000
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology, 2000, Oct-24, Volume: 55, Issue:8 Topics: Aged; Analysis of Variance; Depressive Disorder; Female; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Psychomotor Performance	2000
The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. The American journal of psychiatry, 2001, Volume: 158, Issue:1 Topics: Adolescent; Adult; Age Factors; Cerebral Cortex; Depressive Disorder; Down-Regulation; Female; Fluorine Radioisotopes; Humans; Male; Paroxetine; Pyrimidinones; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed; Treatment Outcome	2001
Misdiagnosis of antidepressant discontinuation symptoms. Acta psychiatrica Scandinavica, 2000, Volume: 102, Issue:6 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Diagnosis, Differential; Dothiepin; Female; Humans; Middle Aged; Paroxetine; Substance Withdrawal Syndrome	2000
Serotonergic antidepressants and urinary incontinence. International urogynecology journal and pelvic floor dysfunction, 2000, Volume: 11, Issue:6 Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride	2000
Female sexual dysfunction and antidepressant use. The American journal of psychiatry, 2001, Volume: 158, Issue:2 Topics: Amantadine; Antidepressive Agents; Buspirone; Citalopram; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Meta-Analysis as Topic; Paroxetine; Personality Inventory; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome	2001
Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behavioural brain research, 2001, Mar-15, Volume: 119, Issue:2 Topics: Animals; Arousal; Body Temperature Regulation; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Imipramine; Male; Mice; Motivation; Motor Activity; Paroxetine; Sex Factors	2001
Paxil and self-scratching. Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:1 Topics: Adolescent; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Paroxetine; Self-Injurious Behavior	2001
An ideal trial to test differential onset of antidepressant effect. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 4 Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Humans; Paroxetine; Placebos; Prospective Studies; Research Design; Terminology as Topic; Time Factors; Treatment Outcome	2001
[Depressive disorders in neurologic rehabilitation: therapy with paroxetine]. Psychiatrische Praxis, 2001, Volume: 28, Issue:1 Topics: Adult; Aged; Brain Diseases; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Stroke; Stroke Rehabilitation; Treatment Outcome	2001
Drug induced akathisia, suicidal ideation and its treatment in the elderly. International journal of geriatric psychiatry, 2001, Volume: 16, Issue:2 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors	2001
Antidepressant treatment and global tests of coagulation and fibrinolysis. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:2 Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Blood Coagulation Tests; Depressive Disorder; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2 Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Hyponatraemia associated with the use of a selective serotonin-reuptake inhibitor in an older patient. Age and ageing, 2001, Volume: 30, Issue:1 Topics: Aged; Depressive Disorder; Female; Head Injuries, Closed; Humans; Hyponatremia; Inappropriate ADH Syndrome; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population. Managed care interface, 2001, Volume: 14, Issue:4 Topics: Adolescent; Adult; Depressive Disorder; Drug Costs; Episode of Care; Fluoxetine; Humans; Managed Care Programs; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	2001
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. The American journal of psychiatry, 2001, Volume: 158, Issue:6 Topics: Adult; Brain; Depressive Disorder; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Hippocampus; Humans; Limbic System; Male; Middle Aged; Parietal Lobe; Paroxetine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed; Treatment Outcome	2001
Does mirtazapine have a more rapid onset than SSRIs? The Journal of clinical psychiatry, 2001, Volume: 62, Issue:5 Topics: Antidepressive Agents, Tricyclic; Citalopram; Cross-Sectional Studies; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Mianserin; Mirtazapine; Paroxetine; Patient Dropouts; Placebo Effect; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2001
Type II error and antidepressants. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:5 Topics: Age Factors; Aged; Antidepressive Agents; Bupropion; Delayed-Action Preparations; Depressive Disorder; Drug Therapy, Combination; False Negative Reactions; Humans; Paroxetine; Patient Selection; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Research Design; Treatment Outcome	2001
Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. Journal of child and adolescent psychopharmacology, 2001,Summer, Volume: 11, Issue:2 Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Motivation; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Paroxetine for the prevention of depression induced by interferon alfa. The New England journal of medicine, 2001, Aug-02, Volume: 345, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Antiviral Agents; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Paroxetine; Recombinant Proteins	2001
Remission of SSRI-induced akathisia after switch to nefazodone. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:7 Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles	2001
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions. Prescrire international, 1999, Volume: 8, Issue:43 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1999
Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders. Acta psychiatrica Scandinavica, 2001, Volume: 104, Issue:3 Topics: Adult; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Sertraline	2001
Decreased platelet [3H]paroxetine binding sites in suicide attempters. Psychiatry research, 2001, Sep-20, Volume: 103, Issue:2-3 Topics: Adolescent; Adult; Bipolar Disorder; Carrier Proteins; Comorbidity; Depressive Disorder; Female; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Radioligand Assay; Receptors, Drug; Risk Factors; Serotonin Plasma Membrane Transport Proteins; Suicide, Attempted	2001
[Depression and anxiety. Broad spectrum SSRI to control both]. MMW Fortschritte der Medizin, 2001, Sep-06, Volume: 143, Issue:35-36 Topics: Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2001
Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:5 Topics: Adult; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2001
Paroxetine in the treatment of tinnitus. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2001, Volume: 125, Issue:4 Topics: Depressive Disorder; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tinnitus	2001
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms. Medicinski arhiv, 2001, Volume: 55, Issue:1 Suppl 1 Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare	2001
Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:2 Topics: Adolescent; Adult; Depressive Disorder; Drug Administration Schedule; Drug Costs; Female; Fluoxetine; Health Care Costs; Health Maintenance Organizations; Humans; Insurance, Pharmaceutical Services; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors	2002
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:2 Topics: Adult; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Inactivation, Metabolic; Male; Metabolic Clearance Rate; Methadone; Opioid-Related Disorders; Paroxetine	2002
Are paroxetine, fluoxetine, and sertraline equally effective for depression? The Journal of family practice, 2002, Volume: 51, Issue:3 Topics: Adult; Depressive Disorder; Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
[Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate]. Nederlands tijdschrift voor geneeskunde, 2002, Apr-27, Volume: 146, Issue:17 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Paroxetine	2002
Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6 Topics: Adolescent; Adult; Aged; Antiviral Agents; Depressive Disorder; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Paroxetine; Patient Compliance; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2002
Serotonin syndrome - 'potential' role of the CYP2D6 genetic polymorphism in Asians. The international journal of neuropsychopharmacology, 2002, Volume: 5, Issue:1 Topics: Adult; Asian People; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Humans; Paroxetine; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2002
Course and rate of antidepressant response in the very old. Journal of affective disorders, 2002, Volume: 69, Issue:1-3 Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Regression Analysis; Time Factors	2002
Platelet paroxetine binding in alcoholics. Alcohol and alcoholism (Oxford, Oxfordshire), 1992, Volume: 27, Issue:6 Topics: Adult; Aged; Alcoholism; Anxiety Disorders; Binding Sites; Blood Platelets; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin	1992
Selective Serotonin Reuptake Inhibitors in Psychiatric Practice. Proceedings of a symposium. Copenhagen, Denmark, March 22, 1991. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Depressive Disorder; Humans; Paroxetine	1992
The advantages of paroxetine in different subgroups of depression. International clinical psychopharmacology, 1992, Volume: 6 Suppl 4 Topics: Anxiety; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxetine; Psychiatric Status Rating Scales; Sleep; Suicide Prevention	1992
Novel selective serotonin reuptake inhibitors, Part I. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:3 Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Humans; Incidence; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Seizures; Serotonin; Suicide	1992
No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine. The British journal of psychiatry : the journal of mental science, 1991, Volume: 158 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Combined Modality Therapy; Depressive Disorder; Drug Hypersensitivity; Female; Follow-Up Studies; Humans; Liver Function Tests; Male; Paroxetine; Piperidines; Serotonin Antagonists; Zimeldine	1991
Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression. Drug and therapeutics bulletin, 1991, Jun-10, Volume: 29, Issue:12 Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Humans; Paroxetine; Piperidines; Sertraline	1991
Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat. Psychiatry research, 1991, Volume: 38, Issue:2 Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Depressive Disorder; Imipramine; Male; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists	1991
Symmetrical hemispheric distribution of 3H-paroxetine binding sites in postmortem human brain from controls and suicides. Biological psychiatry, 1990, Sep-15, Volume: 28, Issue:6 Topics: Adult; Brain; Brain Mapping; Depressive Disorder; Dominance, Cerebral; Female; Frontal Lobe; Humans; Male; Middle Aged; Paroxetine; Piperidines; Putamen; Receptors, Serotonin; Retrospective Studies; Serotonin Antagonists; Substantia Nigra; Suicide	1990
Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain research, 1990, Aug-27, Volume: 526, Issue:1 Topics: Brain Chemistry; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Receptors, Serotonin; Retrospective Studies; Serotonin Antagonists; Suicide; Tritium	1990
Why some depressed patients may have low platelet 3H-imipramine binding. Acta psychiatrica Scandinavica, 1990, Volume: 82, Issue:4 Topics: Antidepressive Agents; Blood Platelets; Carrier Proteins; Cell Membrane; Clomipramine; Depressive Disorder; Humans; Imipramine; Paroxetine; Piperidines; Receptors, Drug; Receptors, Neurotransmitter; Serotonin Antagonists	1990
Introduction to the development of paroxetine, a novel antidepressant. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Depressive Disorder; Humans; Paroxetine; Piperidines; Serotonin Antagonists	1989
Antidepressants and the peripheral nervous system. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Electromyography; Humans; Neural Conduction; Paroxetine; Peripheral Nerves; Piperidines; Serotonin Antagonists	1989
Paroxetine plasma levels: lack of correlation with efficacy or adverse events. Acta psychiatrica Scandinavica. Supplementum, 1989, Volume: 350 Topics: Antidepressive Agents; Depressive Disorder; Humans; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Retrospective Studies; Serotonin Antagonists	1989
Brain 5-HT uptake sites, labelled with [3H]-paroxetine, in post-mortem samples from depressed suicide victims. British journal of pharmacology, 1989, Volume: 98 Suppl Topics: Adult; Brain; Depressive Disorder; Female; Humans; In Vitro Techniques; Male; Paroxetine; Piperidines; Receptors, Serotonin; Serotonin Antagonists; Suicide	1989
Platelet 3H-paroxetine binding in depressed patients. Psychiatry research, 1988, Volume: 26, Issue:1 Topics: Adult; Antidepressive Agents; Blood Platelets; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychological Tests; Serotonin	1988
First results of an open phase II study with the antidepressant paroxetine. Pharmacopsychiatry, 1988, Volume: 21, Issue:6 Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Drug Evaluation; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales	1988
Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression. Journal of receptor research, 1987, Volume: 7, Issue:1-4 Topics: Animals; Antidepressive Agents; Blood Platelets; Brain Chemistry; Carrier Proteins; Depressive Disorder; Female; Humans; Imipramine; Male; Paroxetine; Piperidines; Rabbits; Rats; Receptors, Drug; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin	1987